US20120157971A1 - Vascular access system - Google Patents
Vascular access system Download PDFInfo
- Publication number
- US20120157971A1 US20120157971A1 US13/330,360 US201113330360A US2012157971A1 US 20120157971 A1 US20120157971 A1 US 20120157971A1 US 201113330360 A US201113330360 A US 201113330360A US 2012157971 A1 US2012157971 A1 US 2012157971A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- braided structure
- proximal
- connector
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0009—Making of catheters or other medical or surgical tubes
- A61M25/0014—Connecting a tube to a hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3655—Arterio-venous shunts or fistulae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M2025/0024—Expandable catheters or sheaths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
Definitions
- This application relates to a system for connecting multiple portions of a fluid carrying conduit.
- Permanent vascular access sites for performing hemodialysis may be formed by creating an arteriovenous (AV) anastomosis whereby a vein is attached to an artery to form a high-flow shunt or fistula.
- AV arteriovenous
- a vein may be directly attached to an artery, but it may take 6 to 8 weeks before the venous section of the fistula has sufficiently matured to provide adequate blood flow for use with hemodialysis.
- AV arteriovenous
- a direct anastomosis may not be feasible in all patients due to anatomical considerations.
- Other patients may require the use of artificial graft material to provide an access site between the arterial and venous vascular systems.
- ePTFE expanded polytetrafluoroethylene
- patency rates of ePTFE access grafts are still not satisfactory, as the overall graft failure rate remains high. Sixty percent of these grafts fail yearly, usually due to stenosis at the venous end. (See Besarab, A & Samararpungavan D., “Measuring the Adequacy of Hemodialysis Access”. Curr Opin Nephrol Hypertens 5(6) 527-531, 1996, Raju, S. “PTFE Grafts for Hemodialysis Access”. Ann Surg 206(5), 666-673, November 1987, Koo Seen Lin, LC & Burnapp, L. “Contemporary Vascular Access Surgery for Chronic Hemodialysis”.
- a system for connecting components of an implantable extravascular blood conduit.
- the blood conduit has a proximal end adapted to couple with a first vascular segment and a distal end adapted to be inserted into a second vascular segment.
- the system comprises a catheter, which can be configured as an outflow component, and a connector.
- the catheter has a proximal portion and a distal portion.
- the distal portion is configured such that when in use the distal portion can freely float within the second vascular segment.
- the proximal portion comprises an elongate body defining an inner wall having an inner perimeter.
- the inner wall also defines a blood flow lumen.
- the proximal portion also includes a braided structure that can be embedded in the catheter body and disposed about the lumen.
- the connector is used to fluidly couple with the proximal portion of the catheter.
- the connector has a connector body that has an outer surface defining a first outer perimeter and an inner surface defining a lumen.
- An engagement feature is disposed on an outer surface of the connector body adjacent a distal end thereof.
- the engagement feature defines a second outer perimeter greater than the first outer perimeter.
- the proximal portion of the catheter has a first configuration in the free state wherein the inner perimeter is less than the first outer perimeter of the connector body.
- the proximal portion of the catheter has a second configuration when in axial compression wherein the braided structure expands to permit the inner perimeter of the catheter body to expand such that the proximal portion of the catheter can be advanced over the engagement feature of the connector body.
- a connector system in another embodiment, includes an engagement mechanism that includes an engagement feature and a braided reinforcement coupled with a proximal portion of a catheter.
- the engagement feature can include one, two, or two or more barbs.
- a catheter for insertion into a blood vessel at a vessel insertion site for delivering blood after dialysis to a location downstream of the vessel insertion site.
- the catheter includes an elongate body and a braided structure.
- the elongate body has a proximal portion, a distal portion, and a lumen extending therebetween along a longitudinal axis.
- the elongate body has an inner surface surrounding the lumen and an outer surface surrounding the inner surface.
- the distal portion of the elongate body defines a cross-sectional area sufficiently small to permit insertion thereof into the blood vessel such that blood flows in the vessel around the distal portion.
- the braided structure has a proximal end and a distal end.
- the braided structure can be embedded within the elongate body.
- the outer surface of the elongate body completely surrounds the braided structure.
- the braided structure extends from the proximal portion of the elongate body toward the distal portion thereof.
- the distal portion of the elongate body and the braided structure are sufficiently flexible such that the catheter can freely float at a vascular location downstream of the vessel insertion site.
- the proximal portion of the elongate body and the braided structure are configured to respond to an axial force by expanding such that the lumen is enlarged along the longitudinal axis for advancement over an engagement feature for coupling the catheter with another blood conduit.
- a kit for accessing blood from a patient's vasculature.
- the kit includes a catheter, a graft portion, and a connector for interconnecting the catheter and the graft portion.
- the connector includes an engagement feature configured to radially deform a proximal portion of the catheter.
- the proximal portion of the catheter includes a reinforcement member that increases the force needed to disconnect the catheter from the connector, such that the force to disconnect is greater than a force to connect the catheter and the connector.
- a method of assembling a blood flow conduit in-situ includes providing a proximal blood conduit portion and a distal blood conduit portion.
- the distal blood conduit portion includes a catheter in some embodiments.
- the distal blood conduit can comprise a proximal end portion in which a braided structure is embedded.
- the method includes cutting the distal blood conduit through the braided structure to size the distal blood conduit in-situ and distal blood conduit the catheter to the proximal blood conduit portion.
- FIG. 1 is a perspective view of a vascular access system having a proximal end adapted to couple with a first vascular segment and a distal end adapted for insertion into a second vascular segment;
- FIG. 2 is a perspective view of a catheter that has a distal portion adapted for positioning in a blood vessel and a proximal portion configured to provide an enhanced connection to another blood conduit;
- FIG. 2A is a schematic view of a distal portion of the catheter illustrating techniques for embedding a braided structure therein;
- FIG. 3 is a side view of a reinforcement member configured to be incorporated into the blood flow conduit of FIG. 2 ;
- FIG. 3A is an end view of one braided member of the braided structure of FIG. 3 ;
- FIG. 4 is a plan view of a connector that is adapted to couple a first blood flow conduit with a second blood flow conduit;
- FIG. 5 is a graph illustrating a retention force for various engagement mechanisms described herein;
- FIG. 6 is a graph illustrating a retention force corresponding to various techniques for connecting an engagement mechanism having two barbs
- FIG. 7 is a graph illustrating a retention force for an engagement mechanism having a braided structure with different pic counts.
- FIG. 8 is a graph of attachment forces for various embodiments.
- the fluid carrying conduits are arteriovenous (AV) shunts or catheters in various embodiments. Some of the embodiments described herein may be incorporated into a hemodialysis system.
- AV arteriovenous
- the new connector systems and apparatuses can improve one or more areas of performance of vascular access systems.
- the embodiments described herein improve in-situ connection of a catheter, or other blood-carrying conduit, configured for use as an outflow component, to another component or device of a vascular access system.
- a reinforcement member can be incorporated into the vascular access system (e.g., in a proximal portion of a catheter or other blood carrying conduit) to enhance the security of a connection between a catheter and another component of the vascular access system.
- the reinforcement member also extends through a substantial portion of the length of a blood carrying conduit to improves kink and crush resistance of the fluid carrying conduit.
- Improvements in which these improvements could be used include short-term applications (e.g., several days to a week) and longer-term application.
- short-term applications e.g., several days to a week
- longer-term application e.g., the improvements described herein are useful in longer-term applications of 30 days or more.
- the improvements described herein are useful in longer-term applications of 90 days or more.
- the improvements described herein are useful in long-term applications of 1 year or more.
- the embodiments described herein can be incorporated into short-term and into longer-term applications for dialysis.
- a braided structure can be incorporated into a fluid-carrying conduit.
- the braided structure can be embedded in an elongate body of the fluid-carrying conduit, providing a smooth relatively constant outer surface.
- the braided structure can improve the security or integrity of the connection between the blood-carrying conduit and other structures to which it is attached.
- these innovations provide greater durability and manufacturability.
- the implantation process can be enhanced, such as by providing better connectability and, in some cases, a tactile confirmation of the security of a connection, as discussed below. In some cases, a visual confirmation of the security of a connection can be provided.
- FIG. 1 depicts one embodiment of a vascular access system 10 that is configured to shunt blood from a first vascular segment to a second vascular segment.
- the vascular access system 10 can take any suitable form, but preferably the system is adapted to be implanted beneath the skin of the patient.
- the vascular access system 10 is implanted primarily extravascularly, though a distal portion thereof may reside in or extend through a blood vessel.
- the vascular access system 10 can be partly or completely implanted.
- Various techniques for implanting are discussed below, including placement of at least a portion of the system 10 in a vascular segment.
- the vascular access system 10 can be implanted in a subcutaneous tunnel, as discussed further below. Additional details of processes for implantation are discussed in the patents and applications listed above, which are incorporated by reference herein.
- the vascular access system 10 has a proximal end 14 and a distal end 18 and a lumen 20 that extends between the proximal and distal ends 14 , 18 .
- the proximal end 14 can be adapted to couple with, e.g., attached to, a first vascular segment and the distal end 18 can be adapted to be coupled with, e.g., inserted into a second vascular segment.
- the lumen 20 preferably extends between the proximal and distal ends 14 , 18 and provides a pathway for blood to flow between the first and second vascular segments.
- the lumen 20 also can be accessed from outside the patient to facilitate dialysis or other treatment.
- the first and second vascular segments are arterial or venous vascular segments in various techniques.
- the proximal end 14 can be adapted to be coupled with a brachial artery or other artery that resides close to the skin. Any suitable coupling between the proximal end 14 and the first vascular segment can be used.
- the proximal end 14 can be attached by an end-to-side anastomosis to a brachial artery.
- the distal end 18 can be adapted to couple with or extend into a vein, e.g., in the central venous system, as discussed below and in the application incorporated by reference herein.
- the vascular access system 10 includes a plurality of components that can be assembled to form the lumen 20 .
- a first blood carrying conduit 22 extends from the proximal end 14 toward the distal end 18 and a second blood carrying conduit 26 extends from the distal 18 toward the proximal end 14 .
- a third blood carrying conduit 30 is positioned between the first and second blood carrying conduits 22 , 26 . As discussed below, the third blood carrying conduit 30 is adapted to connect the first and second blood carrying conduits 22 , 26 together in various embodiments.
- the third blood carrying conduit 30 enables the first and second blood carrying conduits 22 , 26 to have different characteristics that are well suited for the unique ways in which these conduits interact with the vasculature.
- the first blood carrying conduit 22 can be specifically configured to be integrated into the vessel with which it is coupled, e.g., by anastomosis connection to an artery.
- the second blood carrying conduit 26 can be specifically configured to interact with a vascular segment to minimize the likelihood of adverse side effects, e.g., by being flexible or otherwise formed to enable a distal portion of the conduit 26 to extend into the central venous system and interact in an atraumatic manner with vessel walls and other tissues in the vasculature or heart.
- this innovation pertains to the unique requirements of a device that perform both as a permanently implanted extravascular graft and as an intravascular catheter.
- the vascular access system 10 can be configured with an engagement mechanism 32 that enhances the security of a connection between two blood carrying conduits of the system.
- the engagement mechanism 32 can include multiple portions with at least one portion located on the second blood carrying conduit 26 and at least one portion is located on the third blood carrying conduit 30 .
- the engagement mechanism 32 is configured such that the connection formed thereby requires a greater force to disconnect than is required to connect the second and third blood carrying conduits 26 , 30 . This provides greater security of and confidence in the connection at the engagement mechanism 32 .
- the engagement mechanism 32 includes an engagement feature 33 located on one of the second and third blood carrying conduits 26 , 30 and an enlargeable portion 34 on the other of the second and third blood carrying conduits 26 , 30 .
- the third blood carrying conduit 30 can include at least one barb and the second blood carrying conduit 26 can be formed to apply an inward and sometimes distally directed force on the barb to resist disconnection of the conduits.
- a distal portion of the third blood carrying conduit 30 includes two barbs.
- the second blood carrying conduit 26 includes a braided structure or other expandable reinforcement member 35 that generates a compressive force on the barb or barbs to enhance the security of the engagement mechanism 32 .
- FIG. 1 only shows the braided structure partially for clarity. As discussed further below, the braided structure can extend to the proximal end 14 and toward the distal end 18 .
- FIG. 1 only shows the braided structure partially for clarity. As discussed further below, the braided structure can extend to the proximal end 14 and toward the distal end 18
- the vascular access system 10 also includes an engagement mechanism 36 that facilitates coupling the first blood carrying conduit 22 with a distal portion of the lumen 20 .
- the engagement mechanism 36 can be incorporated into a proximal portion of a connector.
- the first and third conduits 22 , 30 can be unitary in construction such that the engagement mechanism 36 is not required.
- the first blood carrying conduit 22 can take any suitable form for providing fluid communication between a patient's vascular system and the lumen 20 .
- the first blood carrying conduit 22 is a graft formed of a suitable material, e.g., ePTFE.
- a suitable material e.g., ePTFE.
- Various features for enabling access very soon after implantation, if not immediately thereafter, are discussed in the applications incorporated by reference herein above, including U.S. application Ser. Nos. 11/216,536 (US Publication No. 2006-0064159 A1) and 11/600,589 (US Publication No. 2007-0167901 A1).
- Other suitable biocompatible materials can be used and these will be apparent to one skilled in the art.
- the engagement mechanism is also relevant to other context. Accordingly, the first blood carrying conduit 22 could be a proximal portion of a connector, or a component of another system that conveys blood, e.g., in a ventricular assist device.
- the second blood carrying conduit 26 is configured as a catheter for returning blood to a patient's vasculature.
- the conduit 26 is an outflow component of the system 10 .
- the catheter preferably is adapted such that, in use, at least a distal end portion thereof can freely float within a vascular segment when the vascular access system 10 is applied to a patient. This feature reflects research that indicates that graft failures from localized stenosis at the venous end of AV grafts are primarily due to intimal hyperplasia, compliance mismatch between the graft and the native vein anastomosis, and turbulent flow at the anastomosis site. Kanterman R. Y.
- configuring the second blood carrying conduit 26 e.g., a distal portion thereof to freely float provides atraumatic interaction with the blood vessel.
- Such a configuration also can minimize the likelihood of damage to the vessel in which the distal end portion resides by minimizing trauma to the vessel.
- the conduit 30 or portions thereof can be integrated into another component, e.g., into the first blood carrying conduit 22 .
- the system 10 can be configured with less than three, e.g., only two, separate blood carrying conduits.
- the primary function of the third blood carrying conduit 30 is to couple the first and second blood carrying conduits 22 , 26 and thus the third blood carrying conduit need not be exposed to blood or form a part of the lumen 20 in all embodiments.
- FIG. 2 shows one embodiment of a catheter 100 that can be used in the vascular access system 10 .
- catheter is a broad term that includes any blood carrying conduit that can be at least partially inserted into a blood vessel and advanced therein to a selected location, including into the atrium.
- the catheter 100 can take any suitable form, consistent with the below description.
- the catheter is configured as an outflow component.
- the catheter 100 has a proximal portion 104 , a distal portion 108 , and an elongate body 112 that extends therebetween.
- the catheter 100 is configured such that the proximal portion 104 is connectable over a barb, as discussed below, to enhance securement of the catheter 100 to a connector, which can be incorporated into the conduit 30 .
- the proximal portion 104 preferably also is trimmable such that the length of the catheter 100 can be determined in-situ.
- the catheter 100 also has a sizing region 114 that facilitates customizing the size of the catheter 100 to the patient. In one embodiment, the sizing region 114 is located in the proximal portion 104 of the catheter 100 .
- the sizing region 114 can be trimmed or cut through to reduce the length of the catheter 100 .
- the sizing region 114 is configured to be cut by hand using any standard cutting implement that would be present in the operating room, such as surgical scissors.
- the elongate body 112 preferably defines an inner wall 116 that surrounds a blood flow lumen 120 .
- the inner wall 116 has an inner perimeter 124 that in part defines the blood flow capacity of the catheter 100 .
- the blood flow lumen 120 is substantially cylindrical and the inner wall 116 and the inner perimeter 124 define are substantially circular in cross-section.
- the blood flow lumen 120 has an inner diameter of about 5.0 mm. Lumens of other shapes can be used as well, as will be understood by one skilled in the art.
- Forming the lumen 120 to have a 5.0 mm diameter lumen provides a benefit of being able to handle sufficient blood flow for dialysis while permitting the outer size of the catheter 100 to be small enough to be insertable into the internal jugular vein in one technique.
- the outer size and inner perimeter 124 of the catheter 100 can be substantially constant through the length of the lumen 120 or can vary as will be understood by one skilled in the art.
- the elongate body 112 particularly the inner wall 116 can be configured to provide adequate hemocompatibility such that blood flowing therethrough is not damaged or adversely affected thereby.
- the blood flow lumen 120 preferably is configured to convey blood in a substantially atraumatic manner between the portions 104 , 108 .
- the inner wall 116 is sufficiently smooth in surface finish to minimize turbulence at the wall. If the catheter 100 is integrated into the vascular access system 10 (e.g., as the second blood carrying conduit 26 ), the lumen 120 can form a portion of the lumen 20 . Other portions of the lumen 20 can be defined in one or both of the first and third blood carrying conduits 22 , 30 .
- the catheter 100 preferably is configured such that in use the distal portion 108 can freely float within a vascular segment.
- the system 10 can be applied such that the distal portion 108 is positioned in, extends within, or is inserted through a blood vessel, e.g., in the central venous system.
- the distal portion 108 preferably is configured to have a smaller outer size than the vessel in which it resides. This enables blood to pass around the distal end portion 108 .
- the distal portion 108 can reside in the central venous system in such a manner that blood flows between an outer surface of the distal portion 108 and an inner surface of the blood vessel.
- the distal portion 108 of the catheter 100 has an outer perimeter that is substantially circular with an outer diameter of about 6.1 mm.
- the typical vessel through which the distal portion 108 can be inserted is about 8-20 mm.
- 6.1 mm is a size that is particularly well suited for insertion into an internal jugular vein of an adult human patient. Smaller catheters can be used for certain techniques, e.g., for more peripheral applications.
- the dimensions of the system 10 and the components described herein that can be used in the system 10 are not limiting. Rather the dimensions provide examples of specific embodiments. For other applications, other dimensions may be appropriate.
- the outer diameter of the distal portion 108 of the catheter 100 need not be 6.1 mm but rather would be a function of the vessels into which it is to be inserted. In other applications currently contemplated, the outer diameter of the distal portion 108 could be about four mm to about 8 mm.
- the distal portion 108 preferably is formed to be relatively flexible. The flexibility permits the distal portion 108 to relatively gently interact with the blood vessel in which it resides.
- the catheter 100 is applied through a superficial vessel and is advanced through the internal jugular vein toward the heart. In this environment, a relatively low stiffness construction is sufficient for delivery of the distal portion 108 the catheter 100 .
- FIG. 2A illustrates one approach to making the catheter 100 more flexible in which a soft material is incorporated into the elongate body 112 .
- the elongate body 112 can be formed of any suitable flexible elastomer, such as polyurethane, CFlex, SIBS (styrene isoprene butadiene) or polyolephins.
- silicone tubing can be used in an inner portion 100 A of the catheter 100 . More generally, the elongate body 112 can be formed of an implantable thermoplastic elastomer. In one embodiment, silicone tubing has a durometer of about 50 Shore A or less is used to form the inner portion 100 A of the catheter 100 .
- the catheter 100 can be formed of a material having a durometer of 30-80 Shore A will perform adequately. In other embodiments, a higher or lower durometer material can be used. As further discussed below, there can be particular advantages to the softer durometers of 30-60 Shore A and 40-50 Shore A. As discussed further below, an outer portion 100 B of the catheter 100 can be formed of a similar or the same material as the inner portion 100 A.
- the base material preferably is flexible and base material strength is less critical.
- the ability for the braided tubing to expand radially over a connector barbs is preferred.
- this is an advantage of a braided reinforcement over a single filament, coiled reinforcement, which cannot expand to slip over a barb.
- This is similarly an advantage of braid reinforced tube using a softer base material (such as one with a relatively low durometer, e.g., ⁇ 70 Shore A) over one with a harder base material.
- Forcing a braided tube with a hard base material over a barb would require an unacceptably high force.
- a braided tube with a harder base material would not provide the degree of necking that is desirable in some clinical situations.
- the catheter 100 also can include a braided structure 140 or other reinforcing member between the inner portion 100 A and the outer portion 100 B.
- the braided structure 140 provides a number of benefits to the catheter 100 .
- the braided structure 140 can be configured to contribute to at least in part, resistance to radial compression of the elongate body 112 .
- the braided structure 140 can be configured to provide at least in part, resistance to kinking of the elongate body 112 .
- the braided structure 140 is provided primarily to enhance the security of a connection between the catheter 100 and another component of a blood carrying system, such as the vascular access system 10 .
- the braided structure 140 can enhance the security of an engagement mechanism of which the braided structure forms a part.
- the braided structure 140 includes a proximal end 144 and a distal end 148 .
- the braided structure 140 can be disposed about the lumen 120 , e.g., substantially or completely surrounding the lumen.
- the braided structure 140 also can extend along the lumen 120 such that the proximal end 144 is within the proximal portion 104 of the elongate body 112 and the distal end 148 is within the distal portion 108 of the elongate body.
- the braided structure 140 is configured such that the proximal end 144 extends to or adjacent to the proximal end of the elongate body 112 .
- the braided structure 140 is configured such that the distal end 148 is located proximal of the distal end of the elongate body 112 .
- the distal end 148 of the braided structure 140 can be located about 0.2 inches, about 0.25 inches, or from about 0.2 to about 0.25 inches proximal of the distal end of the catheter 100 .
- This arrangement permits a device for visualization to be located distal of the distal end 148 of the braided structure 140 .
- a radiopaque marker 149 can be located in the distal portion 108 of the elongate body.
- the radiopaque marker 149 is a ring formed of platinum iridium or another radiopaque material.
- any other suitable device to provide the clinician with an indication of where the distal portion 108 of the catheter 100 is located when the blood flow conduit is being advanced in the vasculature can be used instead of the radiopaque marker 149 as will be understood by those skilled in the art.
- the configuration of the braided structure 140 can be varied along the length of the catheter to optimize certain performance metrics of the catheter.
- the distal portion 108 preferably is relatively flexible to minimize trauma to the patient's vasculature. This can be achieved by varying the pic count of the braided structure 140 .
- a proximal portion of the braided structure 140 can be optimized to enhance the connection strength of an engagement mechanism as discussed herein.
- FIG. 2A illustrates that the braided structure 140 can be embedded in the elongate body 112 .
- the braided structure 140 is embedded in the elongate body 112 such that an outer surface of the elongate body 112 surrounds the braided structure 140 .
- the braided structure 140 is disposed within the elongate body 112 such that the outer surface of the elongate body 112 is substantially smooth along the longitudinal axis of the catheter body.
- the braided structure 140 also can be disposed radially outside of the inner wall 116 of the elongate body 112 .
- the braided structure 140 also can be disposed radially between the inner wall 116 of the elongate body 112 and an outer surface thereof.
- the braided structure 140 provides reinforcement that prevents or substantially minimizes kinking, crushing, and other phenomenon that can cause at least partial collapse of the lumen 120 .
- Collapse of the lumen 120 can occur when the catheter 100 traverses a bend of relatively small radius.
- the catheter 100 is required to traverse a joint, such as the shoulder of a patient. Such a traverse could require a relatively small bend radius.
- the catheter 100 need not traverse a small bend radius (e.g., when not crossing a joint).
- a preferred routing of the catheter 100 may cause the conduit to traverse a bend with a radius of about 1.0 inch.
- a preferred routing of the catheter 100 may cause the conduit to traverse a bend with a radius of 1.0 inch or more. In other applications, in a preferred routing the catheter 100 may have to traverse a bend with a radius of about 0.25 inch. In other applications, in a preferred routing the catheter 100 may have to traverse a bend with a radius of about 0.5 inch. In other applications, in a preferred routing the catheter 100 may have to traverse a bend with a radius of between about 0.25 inch and about 1.0 inch. In all of these cases, the braided structure 140 provides a reinforcement to prevent or substantially minimize collapse of the lumen 120 .
- the braided structure 140 is expected to gradually flatten, instead of suddenly inflecting to a kinked configuration. This is advantageous for several reasons.
- gradual flattening of the braided structure 140 will be detectable by a clinician (e.g., using an imaging technology such as X-Ray imaging) such that the clinician can recognize that a less than desirable bend radius is present before full narrowing of the blood conduit occurs.
- a coil reinforcement undergoes higher strain levels and alternating strains than the braided structure 140 . This prevents or delays undesirable fracture or failure due to repeated flexure at very small bend radii.
- the braided structure 140 forms a part of an engagement mechanism, similar to the engagement mechanism 32 .
- FIG. 3 illustrate further details of one embodiment of the braided structure 140 .
- the braided structure 140 has a plurality of braid members 152 that overlap each other in the structure.
- the braided structure 140 can comprise a shape memory material, such as a nickel titanium alloy (e.g., a NITINOL® alloy) in various embodiments.
- a nickel titanium alloy e.g., a NITINOL® alloy
- Other suitable materials include stainless steel (e.g., 304 or 316), titanium, glass, Kevlar and other similar fibrous materials.
- each of the braided members 152 can comprise a nickel titanium alloy or other shape memory material.
- the braided members 152 are woven together to form the braided structure 140 .
- the braid members 152 can have a cross-section with a first transverse dimension D 1 being greater than a second transverse dimension D 2 , the first transverse dimension D 1 being perpendicular to the second transverse dimension D 2 .
- the second transverse dimension D 2 (e.g., the shorter of the two dimensions) is generally radially extending relative to the longitudinal axis of the lumen 120 . These embodiments are illustrated by FIG. 3A .
- Such an arrangement can minimize the thickness of the elongate body 112 between the inner wall 116 and the outer surface of the elongate body. This can result in a very thin structure, e.g., with a thickness of about 2.0 mm or less.
- the thickness of the catheter 100 between the inside wall 116 and an outer surface of the catheter is about 1.1 mm.
- the thickness of the braided member 152 is less than about 50 percent of the thickness of the elongate body 112 .
- the thickness of the braided member 152 is less than about 25 percent of the thickness of the elongate body 112 .
- the thickness of the braided member 152 is about 10 percent of the thickness of the elongate body 112 .
- Minimizing the thickness of the wall of the catheter is important in some embodiments because it can maximize the size of the lumen for carrying blood while still maintaining the ability to insert the catheter 100 into selected vessels.
- the crossing profile of the catheter 100 can be reduced or minimized. Reducing the crossing profile provides an advantage of permitting access to the vascular system through a smaller incision.
- the size of the lumen 120 can be increased for a given crossing profile. Increase in the size of the lumen 120 is advantageous in that it permits greater fluid carrying capacity in the lumen.
- the braided structure 140 provides considerable kink and crush resistance and relative flexibility of the elongate body 112 .
- FIG. 3A provides a plurality of braided members 152 that have elongate cross-sections provided by a plurality of axi-symmetric side-by-side wires.
- a braided member could include two circular cross-section wires provided in a side-by-side arrangement.
- the radial dimension (D 2 ) of the braided members 152 is about equal to the diameter of the wires and the dimension transverse to the radial dimension (D 1 ) is about equal to twice the diameter of the wires.
- One useful construct for the braided members 152 incorporates two 0.005 inch wires that are formed of a nickel titanium alloy. Other embodiments could incorporate 0.006 inch or larger wires.
- Some embodiments could incorporate 0.004 inch or smaller wires. Larger wires may be suitable for larger catheters or for catheters that can use smaller lumens. Smaller wires may be suitable for smaller catheters or for catheters subject to less crush or kink forces.
- the braided members 152 can be formed with one or more flat or oval cross-section wires.
- a suitable alloy would include 56 weight % nickel and 44 weight % titanium. This material can be treated to provide suitable properties, such as by a straight annealing.
- a light oxide finish is suitable for some embodiments.
- Any suitable woven pattern can be provided for creating the braided structure 140 .
- a hopsack weave can be employed in which the braided members 152 cross over a first transverse braided member then cross under a second transverse braided member adjacent the first transverse braided member. This pattern can be repeated throughout the braided structure 140 to provide a suitable weave.
- Hopsack weave is sometimes referred to as a diamond pattern full load.
- the weave could be a diamond pattern half-load or a herringbone weave, which will be understood by one skilled in the art.
- Other weave arrangements that can be used include a linen weave, for example. However, for some applications, the linen weave is not expected to perform as well as other weave patterns discussed herein.
- the braided structure 140 can affect its performance.
- the density and configuration of the braided members 152 can affect the degree of security when the catheter 100 is engaged with another blood carrying component.
- the braided structure 140 is formed with a suitable helix angle, which is defined as the angel between any of the braided members 152 and a longitudinal axis of the braided structure 140 .
- a helix angle within a range of about 40 degrees to about 65 degrees could be used in some embodiments of the braided structure 140 .
- the braided structure 140 can be formed with a helix angle in the range of about 50 degrees to about 55 degrees. In one embodiment the braided structure 140 defines a helix angle of about 51 degrees.
- the braided structure 140 defines a helix angel of about 54 degrees.
- a higher helix angle creates a more flexible catheter.
- a lower helix angle provides less flexibility but is easier to advance over a connector as discussed below.
- Lower helix angle also provides a less crush resistant catheter, which is less optimal in some applications.
- Another aspect of the braided structure 140 that relates to the performance of the engagement mechanism 32 of which the braided structure may be a part is the pic count (crossings per unit length) of the braided structure 140 .
- pic count and helix angle are related. More particularly, pic count can affect the connectability of the catheter 100 with a connector, which can form a part of the third blood carrying conduit 30 . Greater pic count corresponds to a higher force required for coupling the engagement mechanism 32 . Lesser pic count corresponds to lower connecting forces. Catheters with lower pic counts are more subject to kinking.
- the braided structure 140 has a pic count between about 21 ppi and about 24 ppi.
- the braided structure 140 has a pic count of between about 22-24 ppi when assembled on the catheter 100 . In another embodiment, the braided structure 140 has a pic count of about 21 ppi. In another embodiment, the braided structure 140 has a pic count of about 23 ppi. In another embodiment, a pic count of 22 ppi would be suitable.
- FIGS. 7 and 8 illustrate a comparison of the retention force and attachment force respectively for various embodiments of an engagement mechanism.
- pic count of a braided structure in a catheter and various aspects of the engagement feature 240 of the connector 200 were varied.
- the variables that were varied in the connector 200 are shown in the table below, with all dimensions being in inches):
- Embodiment 1 0.065 0.065 0.240 0.012 0.012 Embodiment 2 0.065 0.05 0.225 0.012 0.011 Embodiment 3 0.065 0.05 0.240 0.012 0.011 Embodiment 4 0.065 0.04 0.240 0.012 0.009
- FIG. 8 shows a general trend to lower attachment forces for Embodiment 4 compared to other embodiments.
- Embodiment 4 had lower values for the height and the length of the barb 248 .
- FIG. 8 shows that a lower pic count of the braided structure of the catheter can result in a significantly lower attachment force compared to a higher pic count arrangement, where the connector has two barbs. Lowering the attachment force is desirable in some embodiments to provide faster and easier assembling of a vascular access system in-situ for the clinician.
- FIG. 7 shows that for the embodiments described in the table above, retention force (e.g., the force needed to disconnect the catheter 100 from the connector 200 ) was not highly dependent on pic count for the embodiments of the connector studied. Although there is an increase in retention force for Embodiment 2 compared to the other embodiments, all four embodiments had relatively high retention forces compared to an engagement mechanism including a connector with a single barb engaged with a catheter having a braided structure.
- the performance of the braided structure 140 can relate to the number of wires incorporated into the weave.
- the braided structure 140 includes about forty-eight braided members 152 .
- Other numbers of braided members 152 can be provided, however.
- twenty-four braided members 152 can be provided. Fewer wires provide less crush and kink resistance. More wires provide greater resistance in the braided structure 140 to kinking and crushing.
- Other numbers of wires for forming the braided structure 140 can also be used, as will be understood by one skilled in the art.
- the outer portion 100 B is formed in a different process than the inner portion 100 A.
- an elongate tubular section of silicone or a flexible elastomer is slid onto a solid mandrel to provide the inner portion 100 A.
- the tubular section can have a durometer of about 50 shore A or any other suitable hardness as discussed herein.
- the tubular section optionally is loaded with barium sulphate.
- the inner diameter of the tubular section is about 5.0 mm and the outer diameter of the tubular section is about 5.5 mm.
- the braided structure 140 can be placed over the outer surface of the inner portion 100 A.
- the braided structure 140 can have a diameter of about the same as that of the tubular section outer diameter. In one embodiment, the braided structure 140 has an inner diameter of about 5.5 mm. In one embodiment, the braided structure 140 has an inner diameter of slightly less than the outer diameter of the tubular section. For example, an inner diameter of about 5.4 mm for the braided structure 140 would be suitable. This arrangement causes the braided structure 140 to cinch down on the outer surface of the tubular section forming the inner portion 100 A. In one technique, the braided structure 140 is sized such that its length is substantially the same as or slightly less than that of the tubular section.
- a platinum iridium marker band (or visualization device of other configuration) is positioned over the inner portion 100 A. This can be achieved by sliding the marker band over the distal end to a location between the distal end of the braided structure and the distal end of the tubular section.
- strands of the braided structure 140 can be configured to be visible using radiography or another similar technique.
- the assembly formed to this point in the process can be covered with a suitable material to form the outer portion 100 B of the catheter 100 .
- the assembly can be coated with a suitable material to form the outer portion 100 B of the catheter 100 .
- the outer portion 100 B is formed by dip or spray coating silicone, polyurethane or other suitable material over the assembly.
- the outer layer can placed over the assembly and bonded, shrunk, thermally fused or otherwise formed together.
- the outer layer can be formed by in-line extrusion over the assembly.
- the construct can be cut to size and luer fittings (or other suitable connectors) can be formed on a proximal end thereof as needed.
- luer fittings or other suitable connectors
- the braided structure 140 extends to the proximal portion 108 of the catheter 100 . At least the portion of the braided structure 140 that so extends can interface with the blood carrying conduit 30 forming a part of the engagement mechanism 32 .
- FIG. 4 illustrates one embodiment of a connector 200 that can be incorporated into the blood carrying conduit 30 of the system 10 .
- the connector 200 includes a connector body 202 that has a proximal portion 204 , a distal portion 208 , and lumen 212 extending therebetween.
- the lumen 212 can take any suitable form.
- the lumen 212 includes a tapered section similar to that described in U.S. application Ser. No. 10/962,200.
- the proximal portion 204 preferably is configured to interface with, e.g., be coupled to, the blood carrying conduit 22 .
- the connection between the connector 200 and the conduit 22 can be achieved in any suitable manner.
- the proximal portion 204 can have an enlarged portion 214 over which the conduit 22 can be advanced.
- the enlarged portion 214 can comprise a portion of the engagement mechanism 36 .
- Other techniques and structures for connecting the connector 200 and the conduit 22 are described in the applications incorporated by reference herein above, including U.S. application Ser. Nos. 11/216,536 and 11/600,589.
- the distal portion 208 is configured to interface with the blood carrying conduit 26 or with the catheter 100 .
- the distal portion 208 includes an outer surface 220 that extends between a distal end 224 and a proximal end 228 of the connector 200 .
- the outer surface 220 extends from the distal end 224 to a proximal end of the distal portion 208 , adjacent to an enlarged segment 250 .
- the connector 200 also includes an engagement feature 240 that is disposed on the outer surface 220 .
- the engagement feature 240 comprises a portion of an engagement mechanism.
- the engagement feature 240 can take any suitable form.
- the connector body 202 has a first outer size CB 1 and the engagement feature 240 has a second outer size CB 2 that is greater than the first outer size CB 1 .
- the outer sizes CB 1 , CB 2 can correspond to diameters in one embodiment, but could correspond to outer perimeters.
- CB 1 is a diameter of about 5.4 mm.
- CB 2 is a diameter of about 6.0 mm.
- the inner diameter of the catheter 100 is about 5.0 mm in one embodiment. This corresponds to a prestressing of about 1 mm in the diameter of the catheter 100 .
- a prestressing of about 20% of the inner diameter of a catheter being inserted over the engagement feature 240 can provide suitable connectability.
- a suitable amount of prestressing e.g. enlargement of the inner diameter of a catheter connected over the engagement feature 240
- a suitable amount of prestressing can range from 16-24%.
- a suitable amount of prestressing e.g. enlargement of the inner diameter of a catheter connected over the engagement feature 240
- Prestressing, or stretching the inner size of the catheter 100 creates an enhanced security of the connection formed by the engagement mechanism 32 .
- the braided structure 140 and the proximal portion of the catheter 100 expand upon being placed in compression during the distal advancement of the connector 200 relative to the catheter. After advancement, the braided structure 140 seeks to return to its pre-formed shape, which produced an inwardly directed force on the connector 200 increasing the security of the engagement between the connector 200 and the catheter 100 .
- the configuration of the braided structure 140 is such that if a force for disconnecting the connector 200 and the catheter 100 is applied, the braided structure will increase the inwardly directed force further securing the connection. This action at the engagement mechanism is analogous to a Chinese finger trap toy, which reduces in cross-sectional size upon elongation.
- the engagement feature 240 includes a barb 244 that extends over a portion of the connector body 202 .
- the barb 244 can include any structure that includes a raised surface that extends to above the connector body.
- FIG. 4 illustrates that in one embodiment a second barb 248 is provided between the first barb 244 and the proximal portion 204 of the connector 200 .
- the second barb 248 of the engagement feature greatly enhances the security of the connection between the catheter 100 and the connector 200 .
- the second barb 248 can take any suitable form. In some embodiments of the connector 200 , the second barb 248 is smaller than the first barb 244 .
- the second barb 248 can be about 5.8 mm in diameter in one embodiment.
- the first barb 244 can be about 5.99 in diameter.
- the height of the engagement feature 240 can be important.
- Barb height can be measured on the distance from a location of the barb that is farthest radially from an axis of the lumen through the connector 200 to the surface 220 adjacent to the barb 244 , 248 . In one embodiment, this distance is between about 0.005 inches and about 0.020 inches. In one embodiment, the height of the engagement feature is about 0.013 inches. In one embodiment, the height of the engagement feature is about 0.012 inches. In one embodiment, the height of the engagement feature or barb is between about 0.008 inches and about 0.009 inches.
- the height of a first barb of the engagement feature 240 is about 0.012 inches and the height of a second barb of the engagement feature 240 is about 0.008 inches.
- the height and diameter of the engagement features 240 can be increased to increase retention force. In some embodiments, increasing these dimensions may be limited by the force required to advance the connector 200 into the catheter 100 , which is generally done manually.
- Another aspect of the engagement feature 240 is the length thereof or of individual portions thereof.
- one embodiment has two barbs as discussed above.
- a distal-most barb is about 0.065 inches in length, though longer barbs could be used.
- a proximal-most barb is about 0.065 inches in length.
- the proximal-most barb can be shorter or longer.
- the proximal-most barb is about 0.040 inches in length.
- the distal-most barb is 0.065 inches and the proximal most barb is 0.040 inches.
- Two additional features that contribute to the connection in some embodiments are the spacing between the barbs 244 , 248 and the distance that the catheter is advanced past the proximal most barb.
- FIG. 5 demonstrates performance of various barb spacings.
- One configuration was tested with a maximum peak to peak barb spacing of about 0.740 inches.
- This chart shows a general trend of increase in retention force for greater barb spacing. Some of the increase in force observed in the chart could be attributable to a greater length of catheter in contact with the connector apparatus. As the barb spacing increased, so did the total length of connected catheter.
- FIG. 5 can be interpreted to indicate a minimum spacing of approximately 0.100 inches in some embodiments. At lesser barb spacings than this value the retention force drops rapidly. However, at increased spacings greater that this value, the force increases more slowly.
- one technique computed the rates of change as about 7 lbs/0.040 inches before an inflection point and about 1.2 lbs/0.040 inches after the critical point.
- FIG. 5 shows that the dual barb configuration has superior connection strength to a single barb at all barb spacings and more than twice the strength once the peak to peak spacing exceeds about 0.100 inches. Also, the difference between bare silicone and braid reinforced silicone is apparent in FIG. 5 . Note that in addition to the superior performance at any barb spacing, the slope of the line is greater for a braided catheter. This may be due in part to an amplified retention force generated by the combination of the retention feature 240 and the braided structure 140 in the catheter 100 upon connection of the catheter to the connector 200 . This highlights the superiority of the braided flexible catheter over alternative designs. More particularly, the braided structure has much greater retention strength for a given barb dimension compared to a non-braided catheter of identical material.
- the braided structure has the ability to further increase the retention strength by the use of multiple barbs on the connector 200 . Also, the use of the braided structure compared to other reinforcements facilitates the use of barbs and optimized barb geometry on the connector 200 . Moreover, the use of a soft elongate body 112 in the catheter 100 allows the braided structure 140 to neck down behind the barb and thereby increase the retention strength.
- the spacing can be any suitable spacing, but as discussed below preferably is at least about 0.100 inches in an arrangement with two barb, or more. In one embodiment, the spacing between the peaks of adjacent barbs 244 , 248 is about 0.229 inches. In one embodiment, the spacing between the peaks is about 0.240 inches.
- FIG. 5 illustrates the vast improvements that can be achieved with the embodiments described above, in some applications an engagement mechanism having less redundancy provides adequate retention force.
- FIG. 5 shows one embodiment where an engagement mechanism with a single barb provides about 10 pounds of retention force. This amount of force is sufficient for some applications.
- FIG. 5 shows that bare silicone generally provides a much lower retention force for various dual barb arrangements a combination of bare silicon and a connector can be sufficient in some arrangements, such as if the silicone is clamped at an outside surface thereof.
- the catheter and connector combination it is preferable to advance the catheter proximally past the proximal-most barb.
- the sensitivity to this variable is illustrated by FIG. 6 .
- a single barb example is illustrated in FIG. 6 .
- the dual barb variable setup demonstrated little or no increase in retention force when the amount past the barb exceeded about 0.125 inches for one embodiment. This suggests that a suitable range for the catheter connection past the barb could be about 2-3 mm (0.080′′-0.120′′) or about 1.5-4 mm (0.060′′-0.160′′) for one embodiment of the catheter and connector combination.
- FIG. 6 shows that a catheter flush with the proximal side of the second barb exceeds the retention strength of a single barb where the catheter is about 0.125 inch or less beyond the proximal side of the single barb.
- Other embodiments provide advancement beyond the retention feature 240 of between about 0.080 inches and 0.120 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by between about 0.060 inches and 0.160 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by about 0.010 or about 0.111 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by between at least about 0.125 inches.
- the engagement mechanism 32 particularly when configured to include portions of the catheter 100 and the connector 200 provides a number of clinical advantages over other arteriovenous shunt devices. Specifically, the combination of at least one of a braided structure and a barb in the engagement mechanism improves the ease of use of the device. As discussed above, the catheter 100 can be cut and connected without the need to further modify a catheter prior to connection. Also, the embodiments discussed herein have improved connectability in that a lesser force can be used to connect the engagement mechanism 32 than would be sufficient to disconnect the mechanism. Also, the system 10 is “one-size-fits-all” because it is configured to be trimmed to any desired length.
- the catheter 100 has many independent braided members 152 within the braided structure 140 .
- the plurality of braided members 152 provides redundant support, which results in improved resistance to clamping and fatigue fracture.
- the plurality of braided members 152 also provides improvement in tensile strength. Compared to other prior approaches, less manufacturing steps are required, reducing the labor and cost of production. Also, it is expected that at least some of the embodiments of the catheter 100 withstand higher radial loads before collapsing and can be placed in a tighter radius without kinking than was possible with prior devices. In at least some applications, improved burst resistance (the ability to withstand high pressures without detaching from the connector or rupturing) can be advantageous but is not required.
- the multiple barb system provides increase in strength even when the catheter is minimally past a second barb.
- Visible deformation e.g., by expansion of the catheter 100 or the braided structure 140 , serves as a visual indication of proper attachment. This allows the user to observe the visible reference to insure that the catheter is past both barbs by referencing the two visible rings as the braided catheter goes over the first and second barbs. If not visible, this expansion can create ribbed portion on the otherwise smooth outer surface of the catheter 100 to provide a tactile confirmation of proper attachment.
- the integrity of the connection provides sufficient strength if inserted less than this amount, e.g., by only one-half of the distance from the barb 248 to the segment 250 . This is expected to result in strength that is almost double when compared to a similar single barb system. When fully inserted it is expected that the strength will be almost tripled.
- a properly designed single barb and braided catheter connection system can be made very secure, e.g., with about six times the retention force as a catheter made from the same material but without the braid.
- the second barb is expected to add at least a 100% increase in retention strength. This makes the engagement mechanism more robust, providing the added benefit of reducing the urgency of optimal insertion of the catheter over the connector to the enlarged section 250 .
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 12/397,275, filed Mar. 3, 2009, titled “VASCULAR ACCESS SYSTEM,” which claims the benefit of U.S. Provisional Application No. 61/034,125, filed Mar. 5, 2008. Each of the above identified application is hereby incorporated by reference herein its entirety. Each of the following applications also is incorporated by reference herein in its entirety: U.S. application Ser. No. 11/600,589, filed Nov. 16, 2006, U.S. application Ser. No. 11/216,536 filed on Aug. 31, 2005, and U.S. application Ser. No. 10/962,200, filed on Oct. 8, 2004.
- 1. Field of the Inventions
- This application relates to a system for connecting multiple portions of a fluid carrying conduit.
- 2. Description of the Related Art
- In the United States, approximately 400,000 people have end-stage renal disease requiring chronic hemodialysis. Permanent vascular access sites for performing hemodialysis may be formed by creating an arteriovenous (AV) anastomosis whereby a vein is attached to an artery to form a high-flow shunt or fistula. A vein may be directly attached to an artery, but it may take 6 to 8 weeks before the venous section of the fistula has sufficiently matured to provide adequate blood flow for use with hemodialysis. Moreover, a direct anastomosis may not be feasible in all patients due to anatomical considerations. Other patients may require the use of artificial graft material to provide an access site between the arterial and venous vascular systems.
- Although many materials that have been used to create prosthetic grafts for arterial replacement have also been tried for dialysis access, expanded polytetrafluoroethylene (ePTFE) is the preferred material. The reasons for this include its ease of needle puncture and particularly low complication rates (pseudo-aneurysm, infection, and thrombosis). However, AV grafts still require time for the graft material to mature prior to use, so that a temporary access device, such as a Quinton catheter, must be inserted into a patient for hemodialysis access until the AV graft has matured. The use of temporary catheter access exposes the patient to additional risk of bleeding and infection, as well as discomfort. Also, patency rates of ePTFE access grafts are still not satisfactory, as the overall graft failure rate remains high. Sixty percent of these grafts fail yearly, usually due to stenosis at the venous end. (See Besarab, A & Samararpungavan D., “Measuring the Adequacy of Hemodialysis Access”. Curr Opin Nephrol Hypertens 5(6) 527-531, 1996, Raju, S. “PTFE Grafts for Hemodialysis Access”. Ann Surg 206(5), 666-673, November 1987, Koo Seen Lin, LC & Burnapp, L. “Contemporary Vascular Access Surgery for Chronic Hemodialysis”. J R Coll Surg 41, 164-169, 1996, and Kumpe, DA & Cohen, MAH “Angioplasty/Thrombolytic Treatment of Failing and Failed Hemodialysis Access Sites: Comparison with Surgical Treatment”. Prog Cardiovasc Dis 34(4), 263-278, 1992, all herein incorporated by reference in their entirety). These failure rates are further increased in higher-risk patients, such as diabetics. These access failures result in disruption in the routine dialysis schedule and create hospital costs of over $2 billion per year. See Sharafuddin, MJA, Kadir, S., et al. “Percutaneous Balloon-assisted aspiration thrombectomy of clotted Hemodialysis access Grafts”. J Vasc Intery Radiol 7(2) 177-183, 1996, herein incorporated by reference in its entirety.
- In one embodiment, a system is provided for connecting components of an implantable extravascular blood conduit. The blood conduit has a proximal end adapted to couple with a first vascular segment and a distal end adapted to be inserted into a second vascular segment. The system comprises a catheter, which can be configured as an outflow component, and a connector. The catheter has a proximal portion and a distal portion. The distal portion is configured such that when in use the distal portion can freely float within the second vascular segment. The proximal portion comprises an elongate body defining an inner wall having an inner perimeter. The inner wall also defines a blood flow lumen. The proximal portion also includes a braided structure that can be embedded in the catheter body and disposed about the lumen. The connector is used to fluidly couple with the proximal portion of the catheter. The connector has a connector body that has an outer surface defining a first outer perimeter and an inner surface defining a lumen. An engagement feature is disposed on an outer surface of the connector body adjacent a distal end thereof. The engagement feature defines a second outer perimeter greater than the first outer perimeter. The proximal portion of the catheter has a first configuration in the free state wherein the inner perimeter is less than the first outer perimeter of the connector body. The proximal portion of the catheter has a second configuration when in axial compression wherein the braided structure expands to permit the inner perimeter of the catheter body to expand such that the proximal portion of the catheter can be advanced over the engagement feature of the connector body.
- In another embodiment, a connector system is provided. The connector system includes an engagement mechanism that includes an engagement feature and a braided reinforcement coupled with a proximal portion of a catheter. The engagement feature can include one, two, or two or more barbs.
- In another embodiment, a catheter is provided for insertion into a blood vessel at a vessel insertion site for delivering blood after dialysis to a location downstream of the vessel insertion site. The catheter includes an elongate body and a braided structure. The elongate body has a proximal portion, a distal portion, and a lumen extending therebetween along a longitudinal axis. The elongate body has an inner surface surrounding the lumen and an outer surface surrounding the inner surface. The distal portion of the elongate body defines a cross-sectional area sufficiently small to permit insertion thereof into the blood vessel such that blood flows in the vessel around the distal portion. The braided structure has a proximal end and a distal end. The braided structure can be embedded within the elongate body. In one embodiment, the outer surface of the elongate body completely surrounds the braided structure. The braided structure extends from the proximal portion of the elongate body toward the distal portion thereof. The distal portion of the elongate body and the braided structure are sufficiently flexible such that the catheter can freely float at a vascular location downstream of the vessel insertion site. The proximal portion of the elongate body and the braided structure are configured to respond to an axial force by expanding such that the lumen is enlarged along the longitudinal axis for advancement over an engagement feature for coupling the catheter with another blood conduit.
- A kit is provided for accessing blood from a patient's vasculature. The kit includes a catheter, a graft portion, and a connector for interconnecting the catheter and the graft portion. The connector includes an engagement feature configured to radially deform a proximal portion of the catheter. The proximal portion of the catheter includes a reinforcement member that increases the force needed to disconnect the catheter from the connector, such that the force to disconnect is greater than a force to connect the catheter and the connector.
- In another embodiment, a method of assembling a blood flow conduit in-situ is provided. The method includes providing a proximal blood conduit portion and a distal blood conduit portion. The distal blood conduit portion includes a catheter in some embodiments. The distal blood conduit can comprise a proximal end portion in which a braided structure is embedded. The method includes cutting the distal blood conduit through the braided structure to size the distal blood conduit in-situ and distal blood conduit the catheter to the proximal blood conduit portion.
- The structure and method of using the invention will be better understood with the following detailed description of embodiments of the invention, along with the accompanying illustrations, in which:
-
FIG. 1 is a perspective view of a vascular access system having a proximal end adapted to couple with a first vascular segment and a distal end adapted for insertion into a second vascular segment; -
FIG. 2 is a perspective view of a catheter that has a distal portion adapted for positioning in a blood vessel and a proximal portion configured to provide an enhanced connection to another blood conduit; -
FIG. 2A is a schematic view of a distal portion of the catheter illustrating techniques for embedding a braided structure therein; -
FIG. 3 is a side view of a reinforcement member configured to be incorporated into the blood flow conduit ofFIG. 2 ; -
FIG. 3A is an end view of one braided member of the braided structure ofFIG. 3 ; -
FIG. 4 is a plan view of a connector that is adapted to couple a first blood flow conduit with a second blood flow conduit; -
FIG. 5 is a graph illustrating a retention force for various engagement mechanisms described herein; -
FIG. 6 is a graph illustrating a retention force corresponding to various techniques for connecting an engagement mechanism having two barbs; -
FIG. 7 is a graph illustrating a retention force for an engagement mechanism having a braided structure with different pic counts; and -
FIG. 8 is a graph of attachment forces for various embodiments. - This application relates to new vascular access systems, new connector systems, and new fluid-carrying conduits. The fluid carrying conduits are arteriovenous (AV) shunts or catheters in various embodiments. Some of the embodiments described herein may be incorporated into a hemodialysis system.
- Hemodialysis treatments and vascular access devices therefore are discussed in greater detail in U.S. patent application Ser. Nos. 10/962,200 (US Publication No. 2005-0137614-A1), 11/216,536 (US Publication No. 2006-0064159 A1), and 11/600,589 (US Publication No. 2007-0167901 A1) and in U.S. Pat. Nos. 6,102,884 and 6,582,409. The embodiments described herein can be combined with the systems and methods of any of these applications and patents, all of which are hereby incorporated by reference in their entirety.
- As will be understood in view of the description herein provided, the new connector systems and apparatuses can improve one or more areas of performance of vascular access systems. For example, the embodiments described herein improve in-situ connection of a catheter, or other blood-carrying conduit, configured for use as an outflow component, to another component or device of a vascular access system.
- In some embodiments, a reinforcement member can be incorporated into the vascular access system (e.g., in a proximal portion of a catheter or other blood carrying conduit) to enhance the security of a connection between a catheter and another component of the vascular access system. In some cases, the reinforcement member also extends through a substantial portion of the length of a blood carrying conduit to improves kink and crush resistance of the fluid carrying conduit. These and other advantages of the new devices and methods described herein could be useful in a number of environments that employ a vascular access system, such as vascular access devices, ventricular assist devices, total artificial hearts, and various types of hemodialysis systems.
- Environments in which these improvements could be used include short-term applications (e.g., several days to a week) and longer-term application. For example, the improvements described herein are useful in longer-term applications of 30 days or more. The improvements described herein are useful in longer-term applications of 90 days or more. In some cases, the improvements described herein are useful in long-term applications of 1 year or more. The embodiments described herein can be incorporated into short-term and into longer-term applications for dialysis.
- As will be discussed below, a braided structure can be incorporated into a fluid-carrying conduit. In some embodiments, the braided structure can be embedded in an elongate body of the fluid-carrying conduit, providing a smooth relatively constant outer surface. The braided structure can improve the security or integrity of the connection between the blood-carrying conduit and other structures to which it is attached. In various embodiments, these innovations provide greater durability and manufacturability. In addition, the implantation process can be enhanced, such as by providing better connectability and, in some cases, a tactile confirmation of the security of a connection, as discussed below. In some cases, a visual confirmation of the security of a connection can be provided.
-
FIG. 1 depicts one embodiment of avascular access system 10 that is configured to shunt blood from a first vascular segment to a second vascular segment. Thevascular access system 10 can take any suitable form, but preferably the system is adapted to be implanted beneath the skin of the patient. In one embodiment, thevascular access system 10 is implanted primarily extravascularly, though a distal portion thereof may reside in or extend through a blood vessel. Thevascular access system 10 can be partly or completely implanted. Various techniques for implanting are discussed below, including placement of at least a portion of thesystem 10 in a vascular segment. Also, thevascular access system 10 can be implanted in a subcutaneous tunnel, as discussed further below. Additional details of processes for implantation are discussed in the patents and applications listed above, which are incorporated by reference herein. - The
vascular access system 10 has aproximal end 14 and adistal end 18 and alumen 20 that extends between the proximal and distal ends 14, 18. Theproximal end 14 can be adapted to couple with, e.g., attached to, a first vascular segment and thedistal end 18 can be adapted to be coupled with, e.g., inserted into a second vascular segment. Thelumen 20 preferably extends between the proximal and distal ends 14, 18 and provides a pathway for blood to flow between the first and second vascular segments. Thelumen 20 also can be accessed from outside the patient to facilitate dialysis or other treatment. - The first and second vascular segments are arterial or venous vascular segments in various techniques. For example, the
proximal end 14 can be adapted to be coupled with a brachial artery or other artery that resides close to the skin. Any suitable coupling between theproximal end 14 and the first vascular segment can be used. In one embodiment theproximal end 14 can be attached by an end-to-side anastomosis to a brachial artery. Thedistal end 18 can be adapted to couple with or extend into a vein, e.g., in the central venous system, as discussed below and in the application incorporated by reference herein. - In one embodiment, the
vascular access system 10 includes a plurality of components that can be assembled to form thelumen 20. In one embodiment, a firstblood carrying conduit 22 extends from theproximal end 14 toward thedistal end 18 and a secondblood carrying conduit 26 extends from the distal 18 toward theproximal end 14. In one embodiment a thirdblood carrying conduit 30 is positioned between the first and secondblood carrying conduits blood carrying conduit 30 is adapted to connect the first and secondblood carrying conduits - Where provided, the third
blood carrying conduit 30 enables the first and secondblood carrying conduits blood carrying conduit 22 can be specifically configured to be integrated into the vessel with which it is coupled, e.g., by anastomosis connection to an artery. Also, the secondblood carrying conduit 26 can be specifically configured to interact with a vascular segment to minimize the likelihood of adverse side effects, e.g., by being flexible or otherwise formed to enable a distal portion of theconduit 26 to extend into the central venous system and interact in an atraumatic manner with vessel walls and other tissues in the vasculature or heart. Thus, this innovation pertains to the unique requirements of a device that perform both as a permanently implanted extravascular graft and as an intravascular catheter. - The
vascular access system 10 can be configured with anengagement mechanism 32 that enhances the security of a connection between two blood carrying conduits of the system. Theengagement mechanism 32 can include multiple portions with at least one portion located on the secondblood carrying conduit 26 and at least one portion is located on the thirdblood carrying conduit 30. In some embodiments, theengagement mechanism 32 is configured such that the connection formed thereby requires a greater force to disconnect than is required to connect the second and thirdblood carrying conduits engagement mechanism 32. - In various embodiments, the
engagement mechanism 32 includes anengagement feature 33 located on one of the second and thirdblood carrying conduits enlargeable portion 34 on the other of the second and thirdblood carrying conduits blood carrying conduit 30 can include at least one barb and the secondblood carrying conduit 26 can be formed to apply an inward and sometimes distally directed force on the barb to resist disconnection of the conduits. In one embodiment, a distal portion of the thirdblood carrying conduit 30 includes two barbs. In one embodiment, the secondblood carrying conduit 26 includes a braided structure or otherexpandable reinforcement member 35 that generates a compressive force on the barb or barbs to enhance the security of theengagement mechanism 32.FIG. 1 only shows the braided structure partially for clarity. As discussed further below, the braided structure can extend to theproximal end 14 and toward thedistal end 18. Various additional examples of features of engagement mechanisms are discussed below. - In some embodiments, the
vascular access system 10 also includes anengagement mechanism 36 that facilitates coupling the firstblood carrying conduit 22 with a distal portion of thelumen 20. As discussed further below, theengagement mechanism 36 can be incorporated into a proximal portion of a connector. In other embodiments, the first andthird conduits engagement mechanism 36 is not required. - The first
blood carrying conduit 22 can take any suitable form for providing fluid communication between a patient's vascular system and thelumen 20. In one form the firstblood carrying conduit 22 is a graft formed of a suitable material, e.g., ePTFE. In some applications, it is desirable to provide access to thelumen 20 very soon after implantation of thesystem 10. Various features for enabling access very soon after implantation, if not immediately thereafter, are discussed in the applications incorporated by reference herein above, including U.S. application Ser. Nos. 11/216,536 (US Publication No. 2006-0064159 A1) and 11/600,589 (US Publication No. 2007-0167901 A1). Other suitable biocompatible materials can be used and these will be apparent to one skilled in the art. - Although illustrated in an AV shunt context, the engagement mechanism is also relevant to other context. Accordingly, the first
blood carrying conduit 22 could be a proximal portion of a connector, or a component of another system that conveys blood, e.g., in a ventricular assist device. - In one embodiment, the second
blood carrying conduit 26 is configured as a catheter for returning blood to a patient's vasculature. In some embodiments, theconduit 26 is an outflow component of thesystem 10. The catheter preferably is adapted such that, in use, at least a distal end portion thereof can freely float within a vascular segment when thevascular access system 10 is applied to a patient. This feature reflects research that indicates that graft failures from localized stenosis at the venous end of AV grafts are primarily due to intimal hyperplasia, compliance mismatch between the graft and the native vein anastomosis, and turbulent flow at the anastomosis site. Kanterman R. Y. et al “Dialysis access grafts: Anatomic location of venous stenosis and results of angioplasty.” Radiology 195: 135-139, 1995. We hypothesize that these causes could be circumvented by eliminating the venous anastomosis and instead, using a fluid carrying conduit to discharge the blood directly into the venous system. We have developed vascular access system that eliminates the venous anastomosis in the AV shunt, using a catheter element at the venous end and a synthetic graft element anastomosed to the artery in the standard fashion. We believe that such system should eliminate or reduce venous hyperplasia, which is the largest reason for AV shunt failure. - Accordingly, configuring the second blood carrying conduit 26 (e.g., a distal portion thereof) to freely float provides atraumatic interaction with the blood vessel. Such a configuration also can minimize the likelihood of damage to the vessel in which the distal end portion resides by minimizing trauma to the vessel.
- In some embodiments, the
conduit 30 or portions thereof can be integrated into another component, e.g., into the firstblood carrying conduit 22. Thus, thesystem 10 can be configured with less than three, e.g., only two, separate blood carrying conduits. Additionally, the primary function of the thirdblood carrying conduit 30 is to couple the first and secondblood carrying conduits lumen 20 in all embodiments. -
FIG. 2 shows one embodiment of acatheter 100 that can be used in thevascular access system 10. As used herein “catheter” is a broad term that includes any blood carrying conduit that can be at least partially inserted into a blood vessel and advanced therein to a selected location, including into the atrium. Thecatheter 100 can take any suitable form, consistent with the below description. In some embodiments, the catheter is configured as an outflow component. - The
catheter 100 has aproximal portion 104, adistal portion 108, and anelongate body 112 that extends therebetween. In some applications, thecatheter 100 is configured such that theproximal portion 104 is connectable over a barb, as discussed below, to enhance securement of thecatheter 100 to a connector, which can be incorporated into theconduit 30. Theproximal portion 104 preferably also is trimmable such that the length of thecatheter 100 can be determined in-situ. In one embodiment, thecatheter 100 also has a sizingregion 114 that facilitates customizing the size of thecatheter 100 to the patient. In one embodiment, the sizingregion 114 is located in theproximal portion 104 of thecatheter 100. As will be discussed further below, the sizingregion 114 can be trimmed or cut through to reduce the length of thecatheter 100. Preferably the sizingregion 114 is configured to be cut by hand using any standard cutting implement that would be present in the operating room, such as surgical scissors. - The
elongate body 112 preferably defines aninner wall 116 that surrounds ablood flow lumen 120. Theinner wall 116 has aninner perimeter 124 that in part defines the blood flow capacity of thecatheter 100. In one embodiment, theblood flow lumen 120 is substantially cylindrical and theinner wall 116 and theinner perimeter 124 define are substantially circular in cross-section. In one embodiment, theblood flow lumen 120 has an inner diameter of about 5.0 mm. Lumens of other shapes can be used as well, as will be understood by one skilled in the art. Forming thelumen 120 to have a 5.0 mm diameter lumen provides a benefit of being able to handle sufficient blood flow for dialysis while permitting the outer size of thecatheter 100 to be small enough to be insertable into the internal jugular vein in one technique. The outer size andinner perimeter 124 of thecatheter 100 can be substantially constant through the length of thelumen 120 or can vary as will be understood by one skilled in the art. - The
elongate body 112, particularly theinner wall 116 can be configured to provide adequate hemocompatibility such that blood flowing therethrough is not damaged or adversely affected thereby. Theblood flow lumen 120 preferably is configured to convey blood in a substantially atraumatic manner between theportions inner wall 116 is sufficiently smooth in surface finish to minimize turbulence at the wall. If thecatheter 100 is integrated into the vascular access system 10 (e.g., as the second blood carrying conduit 26), thelumen 120 can form a portion of thelumen 20. Other portions of thelumen 20 can be defined in one or both of the first and thirdblood carrying conduits - The
catheter 100 preferably is configured such that in use thedistal portion 108 can freely float within a vascular segment. As discussed elsewhere herein, thesystem 10 can be applied such that thedistal portion 108 is positioned in, extends within, or is inserted through a blood vessel, e.g., in the central venous system. Accordingly, thedistal portion 108 preferably is configured to have a smaller outer size than the vessel in which it resides. This enables blood to pass around thedistal end portion 108. For example, thedistal portion 108 can reside in the central venous system in such a manner that blood flows between an outer surface of thedistal portion 108 and an inner surface of the blood vessel. In one embodiment, thedistal portion 108 of thecatheter 100 has an outer perimeter that is substantially circular with an outer diameter of about 6.1 mm. In comparison, the typical vessel through which thedistal portion 108 can be inserted is about 8-20 mm. Although larger catheters can be used for some patients and for some other applications, 6.1 mm is a size that is particularly well suited for insertion into an internal jugular vein of an adult human patient. Smaller catheters can be used for certain techniques, e.g., for more peripheral applications. - The dimensions of the
system 10 and the components described herein that can be used in thesystem 10 are not limiting. Rather the dimensions provide examples of specific embodiments. For other applications, other dimensions may be appropriate. For example, the outer diameter of thedistal portion 108 of thecatheter 100 need not be 6.1 mm but rather would be a function of the vessels into which it is to be inserted. In other applications currently contemplated, the outer diameter of thedistal portion 108 could be about four mm to about 8 mm. - Additionally, as discussed below, the
distal portion 108 preferably is formed to be relatively flexible. The flexibility permits thedistal portion 108 to relatively gently interact with the blood vessel in which it resides. In one application, thecatheter 100 is applied through a superficial vessel and is advanced through the internal jugular vein toward the heart. In this environment, a relatively low stiffness construction is sufficient for delivery of thedistal portion 108 thecatheter 100. -
FIG. 2A illustrates one approach to making thecatheter 100 more flexible in which a soft material is incorporated into theelongate body 112. In various embodiments, all or a portion of theelongate body 112 can be formed of any suitable flexible elastomer, such as polyurethane, CFlex, SIBS (styrene isoprene butadiene) or polyolephins. In one example, silicone tubing can be used in aninner portion 100A of thecatheter 100. More generally, theelongate body 112 can be formed of an implantable thermoplastic elastomer. In one embodiment, silicone tubing has a durometer of about 50 Shore A or less is used to form theinner portion 100A of thecatheter 100. In some applications, thecatheter 100 can be formed of a material having a durometer of 30-80 Shore A will perform adequately. In other embodiments, a higher or lower durometer material can be used. As further discussed below, there can be particular advantages to the softer durometers of 30-60 Shore A and 40-50 Shore A. As discussed further below, anouter portion 100B of thecatheter 100 can be formed of a similar or the same material as theinner portion 100A. - In various embodiments, the base material preferably is flexible and base material strength is less critical. In this application, the ability for the braided tubing to expand radially over a connector barbs is preferred. As mentioned previously this is an advantage of a braided reinforcement over a single filament, coiled reinforcement, which cannot expand to slip over a barb. This is similarly an advantage of braid reinforced tube using a softer base material (such as one with a relatively low durometer, e.g., <70 Shore A) over one with a harder base material. Forcing a braided tube with a hard base material over a barb would require an unacceptably high force. Furthermore, under the forces anticipated to be applied during in use, a braided tube with a harder base material would not provide the degree of necking that is desirable in some clinical situations.
- The
catheter 100 also can include abraided structure 140 or other reinforcing member between theinner portion 100A and theouter portion 100B. Thebraided structure 140 provides a number of benefits to thecatheter 100. For example, thebraided structure 140 can be configured to contribute to at least in part, resistance to radial compression of theelongate body 112. Also, thebraided structure 140 can be configured to provide at least in part, resistance to kinking of theelongate body 112. - In one embodiment, the
braided structure 140 is provided primarily to enhance the security of a connection between thecatheter 100 and another component of a blood carrying system, such as thevascular access system 10. For example, thebraided structure 140 can enhance the security of an engagement mechanism of which the braided structure forms a part. - In one embodiment, the
braided structure 140 includes aproximal end 144 and adistal end 148. Thebraided structure 140 can be disposed about thelumen 120, e.g., substantially or completely surrounding the lumen. Thebraided structure 140 also can extend along thelumen 120 such that theproximal end 144 is within theproximal portion 104 of theelongate body 112 and thedistal end 148 is within thedistal portion 108 of the elongate body. In one embodiment, thebraided structure 140 is configured such that theproximal end 144 extends to or adjacent to the proximal end of theelongate body 112. - In one embodiment, the
braided structure 140 is configured such that thedistal end 148 is located proximal of the distal end of theelongate body 112. For example, thedistal end 148 of thebraided structure 140 can be located about 0.2 inches, about 0.25 inches, or from about 0.2 to about 0.25 inches proximal of the distal end of thecatheter 100. This arrangement permits a device for visualization to be located distal of thedistal end 148 of thebraided structure 140. For example, aradiopaque marker 149 can be located in thedistal portion 108 of the elongate body. In one embodiment, theradiopaque marker 149 is a ring formed of platinum iridium or another radiopaque material. Any other suitable device to provide the clinician with an indication of where thedistal portion 108 of thecatheter 100 is located when the blood flow conduit is being advanced in the vasculature can be used instead of theradiopaque marker 149 as will be understood by those skilled in the art. - Also, the configuration of the
braided structure 140 can be varied along the length of the catheter to optimize certain performance metrics of the catheter. For example, as discussed herein, thedistal portion 108 preferably is relatively flexible to minimize trauma to the patient's vasculature. This can be achieved by varying the pic count of thebraided structure 140. Additionally, a proximal portion of thebraided structure 140 can be optimized to enhance the connection strength of an engagement mechanism as discussed herein. -
FIG. 2A illustrates that thebraided structure 140 can be embedded in theelongate body 112. In one embodiment, thebraided structure 140 is embedded in theelongate body 112 such that an outer surface of theelongate body 112 surrounds thebraided structure 140. In some cases, thebraided structure 140 is disposed within theelongate body 112 such that the outer surface of theelongate body 112 is substantially smooth along the longitudinal axis of the catheter body. When embedded in theelongate body 112, thebraided structure 140 also can be disposed radially outside of theinner wall 116 of theelongate body 112. Thebraided structure 140 also can be disposed radially between theinner wall 116 of theelongate body 112 and an outer surface thereof. - Although the
catheter 100 is relatively soft, thebraided structure 140 provides reinforcement that prevents or substantially minimizes kinking, crushing, and other phenomenon that can cause at least partial collapse of thelumen 120. Collapse of thelumen 120 can occur when thecatheter 100 traverses a bend of relatively small radius. For example, in some applications thecatheter 100 is required to traverse a joint, such as the shoulder of a patient. Such a traverse could require a relatively small bend radius. In other applications, thecatheter 100 need not traverse a small bend radius (e.g., when not crossing a joint). In some applications, a preferred routing of thecatheter 100 may cause the conduit to traverse a bend with a radius of about 1.0 inch. In some applications, a preferred routing of thecatheter 100 may cause the conduit to traverse a bend with a radius of 1.0 inch or more. In other applications, in a preferred routing thecatheter 100 may have to traverse a bend with a radius of about 0.25 inch. In other applications, in a preferred routing thecatheter 100 may have to traverse a bend with a radius of about 0.5 inch. In other applications, in a preferred routing thecatheter 100 may have to traverse a bend with a radius of between about 0.25 inch and about 1.0 inch. In all of these cases, thebraided structure 140 provides a reinforcement to prevent or substantially minimize collapse of thelumen 120. - Properties of the
braided structure 140 and variations thereof result in desirable kink minimizing properties not achievable using a coil reinforcement. At very small bend diameters, thebraided structure 140 is expected to gradually flatten, instead of suddenly inflecting to a kinked configuration. This is advantageous for several reasons. First, gradual flattening of thebraided structure 140 will be detectable by a clinician (e.g., using an imaging technology such as X-Ray imaging) such that the clinician can recognize that a less than desirable bend radius is present before full narrowing of the blood conduit occurs. Secondly, a coil reinforcement undergoes higher strain levels and alternating strains than thebraided structure 140. This prevents or delays undesirable fracture or failure due to repeated flexure at very small bend radii. In addition, only a fraction of the plurality of members in thebraided structure 140 undergo significant stress or strain level at minimum bend radii. The braid members on the top and bottom of the fold undergo negligible stress compared to the members at the sides of the fold. This means that even if the loading conditions were severe enough to fracture braid members on the sides of the fold, the majority of braid members at the fold would not fracture and the device would remain substantially intact. In previous single filament, coil reinforced devices, any fracture was potentially catastrophic. Also, the disclosed braid configurations advantageously exhibit full narrowing or kinking at a much smaller bend radii than prior coil reinforced devices. Prior coil reinforced devices had a kink radius of approximately 0.5 inch, whereas various embodiments of thecatheter 100 have a kink radius of approximately 0.2 inches. - In some embodiments, the
braided structure 140 forms a part of an engagement mechanism, similar to theengagement mechanism 32. -
FIG. 3 illustrate further details of one embodiment of thebraided structure 140. In one embodiment, thebraided structure 140 has a plurality ofbraid members 152 that overlap each other in the structure. Thebraided structure 140 can comprise a shape memory material, such as a nickel titanium alloy (e.g., a NITINOL® alloy) in various embodiments. Other suitable materials include stainless steel (e.g., 304 or 316), titanium, glass, Kevlar and other similar fibrous materials. For example, each of the braidedmembers 152 can comprise a nickel titanium alloy or other shape memory material. In some embodiments, the braidedmembers 152 are woven together to form thebraided structure 140. Thebraid members 152 can have a cross-section with a first transverse dimension D1 being greater than a second transverse dimension D2, the first transverse dimension D1 being perpendicular to the second transverse dimension D2. In one embodiment, the second transverse dimension D2 (e.g., the shorter of the two dimensions) is generally radially extending relative to the longitudinal axis of thelumen 120. These embodiments are illustrated byFIG. 3A . - Such an arrangement can minimize the thickness of the
elongate body 112 between theinner wall 116 and the outer surface of the elongate body. This can result in a very thin structure, e.g., with a thickness of about 2.0 mm or less. In one embodiment, the thickness of thecatheter 100 between theinside wall 116 and an outer surface of the catheter is about 1.1 mm. In one embodiment, the thickness of thebraided member 152 is less than about 50 percent of the thickness of theelongate body 112. In one embodiment, the thickness of thebraided member 152 is less than about 25 percent of the thickness of theelongate body 112. In one embodiment, the thickness of thebraided member 152 is about 10 percent of the thickness of theelongate body 112. Minimizing the thickness of the wall of the catheter is important in some embodiments because it can maximize the size of the lumen for carrying blood while still maintaining the ability to insert thecatheter 100 into selected vessels. - By reducing the dimension D2, the crossing profile of the
catheter 100 can be reduced or minimized. Reducing the crossing profile provides an advantage of permitting access to the vascular system through a smaller incision. In some embodiments, by reducing the dimension D2, the size of thelumen 120 can be increased for a given crossing profile. Increase in the size of thelumen 120 is advantageous in that it permits greater fluid carrying capacity in the lumen. Thebraided structure 140 provides considerable kink and crush resistance and relative flexibility of theelongate body 112. - One embodiment illustrated by
FIG. 3A provides a plurality of braidedmembers 152 that have elongate cross-sections provided by a plurality of axi-symmetric side-by-side wires. For example, a braided member could include two circular cross-section wires provided in a side-by-side arrangement. In this embodiment, the radial dimension (D2) of the braidedmembers 152 is about equal to the diameter of the wires and the dimension transverse to the radial dimension (D1) is about equal to twice the diameter of the wires. One useful construct for the braidedmembers 152 incorporates two 0.005 inch wires that are formed of a nickel titanium alloy. Other embodiments could incorporate 0.006 inch or larger wires. Some embodiments could incorporate 0.004 inch or smaller wires. Larger wires may be suitable for larger catheters or for catheters that can use smaller lumens. Smaller wires may be suitable for smaller catheters or for catheters subject to less crush or kink forces. In other embodiments, the braidedmembers 152 can be formed with one or more flat or oval cross-section wires. A suitable alloy would include 56 weight % nickel and 44 weight % titanium. This material can be treated to provide suitable properties, such as by a straight annealing. A light oxide finish is suitable for some embodiments. - Any suitable woven pattern can be provided for creating the
braided structure 140. For example, a hopsack weave can be employed in which the braidedmembers 152 cross over a first transverse braided member then cross under a second transverse braided member adjacent the first transverse braided member. This pattern can be repeated throughout thebraided structure 140 to provide a suitable weave. Hopsack weave is sometimes referred to as a diamond pattern full load. In other embodiments, the weave could be a diamond pattern half-load or a herringbone weave, which will be understood by one skilled in the art. Other weave arrangements that can be used include a linen weave, for example. However, for some applications, the linen weave is not expected to perform as well as other weave patterns discussed herein. - Further aspects of the
braided structure 140 can affect its performance. For example, the density and configuration of the braidedmembers 152 can affect the degree of security when thecatheter 100 is engaged with another blood carrying component. For example, in one embodiment, thebraided structure 140 is formed with a suitable helix angle, which is defined as the angel between any of the braidedmembers 152 and a longitudinal axis of thebraided structure 140. A helix angle within a range of about 40 degrees to about 65 degrees could be used in some embodiments of thebraided structure 140. In other embodiments, thebraided structure 140 can be formed with a helix angle in the range of about 50 degrees to about 55 degrees. In one embodiment thebraided structure 140 defines a helix angle of about 51 degrees. In one embodiment thebraided structure 140 defines a helix angel of about 54 degrees. A higher helix angle creates a more flexible catheter. A lower helix angle provides less flexibility but is easier to advance over a connector as discussed below. Lower helix angle also provides a less crush resistant catheter, which is less optimal in some applications. - Another aspect of the
braided structure 140 that relates to the performance of theengagement mechanism 32 of which the braided structure may be a part is the pic count (crossings per unit length) of thebraided structure 140. One skilled in the art will recognize that pic count and helix angle are related. More particularly, pic count can affect the connectability of thecatheter 100 with a connector, which can form a part of the thirdblood carrying conduit 30. Greater pic count corresponds to a higher force required for coupling theengagement mechanism 32. Lesser pic count corresponds to lower connecting forces. Catheters with lower pic counts are more subject to kinking. In one embodiment, thebraided structure 140 has a pic count between about 21 ppi and about 24 ppi. In another embodiment, thebraided structure 140 has a pic count of between about 22-24 ppi when assembled on thecatheter 100. In another embodiment, thebraided structure 140 has a pic count of about 21 ppi. In another embodiment, thebraided structure 140 has a pic count of about 23 ppi. In another embodiment, a pic count of 22 ppi would be suitable. -
FIGS. 7 and 8 illustrate a comparison of the retention force and attachment force respectively for various embodiments of an engagement mechanism. In this study, pic count of a braided structure in a catheter and various aspects of theengagement feature 240 of theconnector 200 were varied. The variables that were varied in theconnector 200 are shown in the table below, with all dimensions being in inches): -
Spacing Between Height Length of Length of Barbs 244Height of of barb Barb 244Barb 248 and 248 barb 244248 Embodiment 10.065 0.065 0.240 0.012 0.012 Embodiment 20.065 0.05 0.225 0.012 0.011 Embodiment 30.065 0.05 0.240 0.012 0.011 Embodiment 40.065 0.04 0.240 0.012 0.009 -
FIG. 8 shows a general trend to lower attachment forces forEmbodiment 4 compared to other embodiments.Embodiment 4 had lower values for the height and the length of thebarb 248. Also,FIG. 8 shows that a lower pic count of the braided structure of the catheter can result in a significantly lower attachment force compared to a higher pic count arrangement, where the connector has two barbs. Lowering the attachment force is desirable in some embodiments to provide faster and easier assembling of a vascular access system in-situ for the clinician. -
FIG. 7 shows that for the embodiments described in the table above, retention force (e.g., the force needed to disconnect thecatheter 100 from the connector 200) was not highly dependent on pic count for the embodiments of the connector studied. Although there is an increase in retention force forEmbodiment 2 compared to the other embodiments, all four embodiments had relatively high retention forces compared to an engagement mechanism including a connector with a single barb engaged with a catheter having a braided structure. - Also, the performance of the
braided structure 140 can relate to the number of wires incorporated into the weave. In some embodiments, thebraided structure 140 includes about forty-eightbraided members 152. Other numbers of braidedmembers 152 can be provided, however. For example, in one embodiment, twenty-fourbraided members 152 can be provided. Fewer wires provide less crush and kink resistance. More wires provide greater resistance in thebraided structure 140 to kinking and crushing. Other numbers of wires for forming thebraided structure 140 can also be used, as will be understood by one skilled in the art. - Various techniques are contemplated for forming the
catheter 100 with inner andouter portions outer portion 100B is formed in a different process than theinner portion 100A. For example, the in a first step of one embodiment, an elongate tubular section of silicone or a flexible elastomer is slid onto a solid mandrel to provide theinner portion 100A. The tubular section can have a durometer of about 50 shore A or any other suitable hardness as discussed herein. The tubular section optionally is loaded with barium sulphate. In one technique, the inner diameter of the tubular section is about 5.0 mm and the outer diameter of the tubular section is about 5.5 mm. - Thereafter, the
braided structure 140 can be placed over the outer surface of theinner portion 100A. Thebraided structure 140 can have a diameter of about the same as that of the tubular section outer diameter. In one embodiment, thebraided structure 140 has an inner diameter of about 5.5 mm. In one embodiment, thebraided structure 140 has an inner diameter of slightly less than the outer diameter of the tubular section. For example, an inner diameter of about 5.4 mm for thebraided structure 140 would be suitable. This arrangement causes thebraided structure 140 to cinch down on the outer surface of the tubular section forming theinner portion 100A. In one technique, thebraided structure 140 is sized such that its length is substantially the same as or slightly less than that of the tubular section. - Thereafter a platinum iridium marker band (or visualization device of other configuration) is positioned over the
inner portion 100A. This can be achieved by sliding the marker band over the distal end to a location between the distal end of the braided structure and the distal end of the tubular section. In another technique, strands of thebraided structure 140, particularly strands located in the distal portion thereof, can be configured to be visible using radiography or another similar technique. - Thereafter, the assembly formed to this point in the process can be covered with a suitable material to form the
outer portion 100B of thecatheter 100. For example, the assembly can be coated with a suitable material to form theouter portion 100B of thecatheter 100. In one technique, theouter portion 100B is formed by dip or spray coating silicone, polyurethane or other suitable material over the assembly. In another technique, the outer layer can placed over the assembly and bonded, shrunk, thermally fused or otherwise formed together. In another technique, the outer layer can be formed by in-line extrusion over the assembly. - Other optional steps can thereafter be performed in various embodiments. For example, the construct can be cut to size and luer fittings (or other suitable connectors) can be formed on a proximal end thereof as needed. The forgoing steps are illustrative and need not be performed in the order recited.
- As discussed above, in various embodiments, the
braided structure 140 extends to theproximal portion 108 of thecatheter 100. At least the portion of thebraided structure 140 that so extends can interface with theblood carrying conduit 30 forming a part of theengagement mechanism 32. -
FIG. 4 illustrates one embodiment of aconnector 200 that can be incorporated into theblood carrying conduit 30 of thesystem 10. Theconnector 200 includes aconnector body 202 that has aproximal portion 204, adistal portion 208, andlumen 212 extending therebetween. Thelumen 212 can take any suitable form. In one embodiment, thelumen 212 includes a tapered section similar to that described in U.S. application Ser. No. 10/962,200. - The
proximal portion 204 preferably is configured to interface with, e.g., be coupled to, theblood carrying conduit 22. The connection between theconnector 200 and theconduit 22 can be achieved in any suitable manner. For example, theproximal portion 204 can have anenlarged portion 214 over which theconduit 22 can be advanced. Theenlarged portion 214 can comprise a portion of theengagement mechanism 36. Other techniques and structures for connecting theconnector 200 and theconduit 22 are described in the applications incorporated by reference herein above, including U.S. application Ser. Nos. 11/216,536 and 11/600,589. - The
distal portion 208 is configured to interface with theblood carrying conduit 26 or with thecatheter 100. In one embodiment, thedistal portion 208 includes anouter surface 220 that extends between adistal end 224 and aproximal end 228 of theconnector 200. In one embodiment, theouter surface 220 extends from thedistal end 224 to a proximal end of thedistal portion 208, adjacent to anenlarged segment 250. Theconnector 200 also includes anengagement feature 240 that is disposed on theouter surface 220. In one embodiment, theengagement feature 240 comprises a portion of an engagement mechanism. - The
engagement feature 240 can take any suitable form. For example, in one embodiment, theconnector body 202 has a first outer size CB1 and theengagement feature 240 has a second outer size CB2 that is greater than the first outer size CB1. The outer sizes CB1, CB2 can correspond to diameters in one embodiment, but could correspond to outer perimeters. In one embodiment, CB1 is a diameter of about 5.4 mm. In one embodiment, CB2 is a diameter of about 6.0 mm. As discussed above, the inner diameter of thecatheter 100 is about 5.0 mm in one embodiment. This corresponds to a prestressing of about 1 mm in the diameter of thecatheter 100. In some embodiments, a prestressing of about 20% of the inner diameter of a catheter being inserted over theengagement feature 240 can provide suitable connectability. In some embodiments, a suitable amount of prestressing (e.g. enlargement of the inner diameter of a catheter connected over the engagement feature 240) can range from 16-24%. In other embodiments, a suitable amount of prestressing (e.g. enlargement of the inner diameter of a catheter connected over the engagement feature 240) can range from 8-28%. - Prestressing, or stretching the inner size of the
catheter 100 creates an enhanced security of the connection formed by theengagement mechanism 32. In particular, thebraided structure 140 and the proximal portion of thecatheter 100 expand upon being placed in compression during the distal advancement of theconnector 200 relative to the catheter. After advancement, thebraided structure 140 seeks to return to its pre-formed shape, which produced an inwardly directed force on theconnector 200 increasing the security of the engagement between theconnector 200 and thecatheter 100. Also, the configuration of thebraided structure 140 is such that if a force for disconnecting theconnector 200 and thecatheter 100 is applied, the braided structure will increase the inwardly directed force further securing the connection. This action at the engagement mechanism is analogous to a Chinese finger trap toy, which reduces in cross-sectional size upon elongation. - Providing one or more barbs creates an even more secure connection. In some embodiments, the
engagement feature 240 includes abarb 244 that extends over a portion of theconnector body 202. Thebarb 244 can include any structure that includes a raised surface that extends to above the connector body. -
FIG. 4 illustrates that in one embodiment asecond barb 248 is provided between thefirst barb 244 and theproximal portion 204 of theconnector 200. As discussed below, thesecond barb 248 of the engagement feature greatly enhances the security of the connection between thecatheter 100 and theconnector 200. Thesecond barb 248 can take any suitable form. In some embodiments of theconnector 200, thesecond barb 248 is smaller than thefirst barb 244. For example, thesecond barb 248 can be about 5.8 mm in diameter in one embodiment. Thefirst barb 244 can be about 5.99 in diameter. - In some embodiments, the height of the engagement feature 240 (e.g., the
barbs 244 or 248) can be important. Barb height can be measured on the distance from a location of the barb that is farthest radially from an axis of the lumen through theconnector 200 to thesurface 220 adjacent to thebarb engagement feature 240 is about 0.012 inches and the height of a second barb of theengagement feature 240 is about 0.008 inches. The height and diameter of the engagement features 240 can be increased to increase retention force. In some embodiments, increasing these dimensions may be limited by the force required to advance theconnector 200 into thecatheter 100, which is generally done manually. - Another aspect of the
engagement feature 240 is the length thereof or of individual portions thereof. For example, one embodiment has two barbs as discussed above. In one arrangement a distal-most barb is about 0.065 inches in length, though longer barbs could be used. In one embodiment, a proximal-most barb is about 0.065 inches in length. The proximal-most barb can be shorter or longer. For example, in one embodiment, the proximal-most barb is about 0.040 inches in length. In one embodiment, the distal-most barb is 0.065 inches and the proximal most barb is 0.040 inches. - Two additional features that contribute to the connection in some embodiments are the spacing between the
barbs -
FIG. 5 demonstrates performance of various barb spacings. One configuration was tested with a maximum peak to peak barb spacing of about 0.740 inches. This chart shows a general trend of increase in retention force for greater barb spacing. Some of the increase in force observed in the chart could be attributable to a greater length of catheter in contact with the connector apparatus. As the barb spacing increased, so did the total length of connected catheter.FIG. 5 can be interpreted to indicate a minimum spacing of approximately 0.100 inches in some embodiments. At lesser barb spacings than this value the retention force drops rapidly. However, at increased spacings greater that this value, the force increases more slowly. InFIG. 5 , one technique computed the rates of change as about 7 lbs/0.040 inches before an inflection point and about 1.2 lbs/0.040 inches after the critical point. This analysis employed a simple linear fit. One skilled in the art will recognize that a more complex fit of the data would produce a different mathematical description of the data. However, it is expected that other such curve fits would still reveal a relatively steep slope toward 0.100 inches and a flatter slope toward the middle of the data. Similarly inFIG. 6 , discussed below, a more complex curve fit might reveal a generally asymptotic profile at one or both ends of the data set. -
FIG. 5 shows that the dual barb configuration has superior connection strength to a single barb at all barb spacings and more than twice the strength once the peak to peak spacing exceeds about 0.100 inches. Also, the difference between bare silicone and braid reinforced silicone is apparent inFIG. 5 . Note that in addition to the superior performance at any barb spacing, the slope of the line is greater for a braided catheter. This may be due in part to an amplified retention force generated by the combination of theretention feature 240 and thebraided structure 140 in thecatheter 100 upon connection of the catheter to theconnector 200. This highlights the superiority of the braided flexible catheter over alternative designs. More particularly, the braided structure has much greater retention strength for a given barb dimension compared to a non-braided catheter of identical material. Also, the braided structure has the ability to further increase the retention strength by the use of multiple barbs on theconnector 200. Also, the use of the braided structure compared to other reinforcements facilitates the use of barbs and optimized barb geometry on theconnector 200. Moreover, the use of a softelongate body 112 in thecatheter 100 allows the braidedstructure 140 to neck down behind the barb and thereby increase the retention strength. - Given the results illustrated in
FIG. 5 , the spacing can be any suitable spacing, but as discussed below preferably is at least about 0.100 inches in an arrangement with two barb, or more. In one embodiment, the spacing between the peaks ofadjacent barbs - Although
FIG. 5 illustrates the vast improvements that can be achieved with the embodiments described above, in some applications an engagement mechanism having less redundancy provides adequate retention force. For example,FIG. 5 shows one embodiment where an engagement mechanism with a single barb provides about 10 pounds of retention force. This amount of force is sufficient for some applications. Also, althoughFIG. 5 shows that bare silicone generally provides a much lower retention force for various dual barb arrangements a combination of bare silicon and a connector can be sufficient in some arrangements, such as if the silicone is clamped at an outside surface thereof. - In various embodiments, it is preferable to advance the catheter proximally past the proximal-most barb. The sensitivity to this variable is illustrated by
FIG. 6 . Also, a single barb example is illustrated inFIG. 6 . The dual barb variable setup demonstrated little or no increase in retention force when the amount past the barb exceeded about 0.125 inches for one embodiment. This suggests that a suitable range for the catheter connection past the barb could be about 2-3 mm (0.080″-0.120″) or about 1.5-4 mm (0.060″-0.160″) for one embodiment of the catheter and connector combination. -
FIG. 6 shows that a catheter flush with the proximal side of the second barb exceeds the retention strength of a single barb where the catheter is about 0.125 inch or less beyond the proximal side of the single barb. Other embodiments provide advancement beyond theretention feature 240 of between about 0.080 inches and 0.120 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by between about 0.060 inches and 0.160 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by about 0.010 or about 0.111 inches. In some embodiments, it is preferable to advance the catheter proximally past the proximal-most barb by between at least about 0.125 inches. - As discussed above, the
engagement mechanism 32 particularly when configured to include portions of thecatheter 100 and theconnector 200 provides a number of clinical advantages over other arteriovenous shunt devices. Specifically, the combination of at least one of a braided structure and a barb in the engagement mechanism improves the ease of use of the device. As discussed above, thecatheter 100 can be cut and connected without the need to further modify a catheter prior to connection. Also, the embodiments discussed herein have improved connectability in that a lesser force can be used to connect theengagement mechanism 32 than would be sufficient to disconnect the mechanism. Also, thesystem 10 is “one-size-fits-all” because it is configured to be trimmed to any desired length. - Other advantages that are provided include improved durability. The
catheter 100 has many independent braidedmembers 152 within thebraided structure 140. The plurality of braidedmembers 152 provides redundant support, which results in improved resistance to clamping and fatigue fracture. The plurality of braidedmembers 152 also provides improvement in tensile strength. Compared to other prior approaches, less manufacturing steps are required, reducing the labor and cost of production. Also, it is expected that at least some of the embodiments of thecatheter 100 withstand higher radial loads before collapsing and can be placed in a tighter radius without kinking than was possible with prior devices. In at least some applications, improved burst resistance (the ability to withstand high pressures without detaching from the connector or rupturing) can be advantageous but is not required. - Other advantages of the embodiments discussed herein include a benefit for the physician to receive feedback indicating that the catheter has been properly connected. For example, the multiple barb system provides increase in strength even when the catheter is minimally past a second barb. Visible deformation, e.g., by expansion of the
catheter 100 or thebraided structure 140, serves as a visual indication of proper attachment. This allows the user to observe the visible reference to insure that the catheter is past both barbs by referencing the two visible rings as the braided catheter goes over the first and second barbs. If not visible, this expansion can create ribbed portion on the otherwise smooth outer surface of thecatheter 100 to provide a tactile confirmation of proper attachment. - Although it is recommended that the catheter be fully advanced against the central
enlarged segment 250 of theconnector 200, the integrity of the connection provides sufficient strength if inserted less than this amount, e.g., by only one-half of the distance from thebarb 248 to thesegment 250. This is expected to result in strength that is almost double when compared to a similar single barb system. When fully inserted it is expected that the strength will be almost tripled. - As discussed above, multiple and single barb engagement features can be suitable for secure connections. A properly designed single barb and braided catheter connection system can be made very secure, e.g., with about six times the retention force as a catheter made from the same material but without the braid. The second barb is expected to add at least a 100% increase in retention strength. This makes the engagement mechanism more robust, providing the added benefit of reducing the urgency of optimal insertion of the catheter over the connector to the
enlarged section 250. - These features provide the desired level of security while providing the end user with both an increase in the confidence of achieving a secure connection.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/330,360 US20120157971A1 (en) | 2008-03-05 | 2011-12-19 | Vascular access system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3412508P | 2008-03-05 | 2008-03-05 | |
US12/397,275 US8079973B2 (en) | 2008-03-05 | 2009-03-03 | Vascular access system |
US13/330,360 US20120157971A1 (en) | 2008-03-05 | 2011-12-19 | Vascular access system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/397,275 Continuation US8079973B2 (en) | 2008-03-05 | 2009-03-03 | Vascular access system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120157971A1 true US20120157971A1 (en) | 2012-06-21 |
Family
ID=40631581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/397,275 Active 2030-01-23 US8079973B2 (en) | 2008-03-05 | 2009-03-03 | Vascular access system |
US13/330,360 Abandoned US20120157971A1 (en) | 2008-03-05 | 2011-12-19 | Vascular access system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/397,275 Active 2030-01-23 US8079973B2 (en) | 2008-03-05 | 2009-03-03 | Vascular access system |
Country Status (7)
Country | Link |
---|---|
US (2) | US8079973B2 (en) |
EP (1) | EP2265300B1 (en) |
JP (1) | JP5492792B2 (en) |
CA (1) | CA2716995C (en) |
ES (1) | ES2574160T3 (en) |
HK (1) | HK1152502A1 (en) |
WO (1) | WO2009111505A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120277729A1 (en) * | 2011-04-29 | 2012-11-01 | Melsheimer Jeffry S | Catheter having a selectively variable degree of flexibility |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7762977B2 (en) | 2003-10-08 | 2010-07-27 | Hemosphere, Inc. | Device and method for vascular access |
US20110295181A1 (en) * | 2008-03-05 | 2011-12-01 | Hemosphere, Inc. | Implantable and removable customizable body conduit |
JP5830028B2 (en) * | 2009-12-14 | 2015-12-09 | タル, マイケル, ジー.TAL, Michael, G. | Intravascular catheter with positioning marker and placement method |
EP2544623B1 (en) | 2010-03-09 | 2018-01-10 | Solinas Medical Inc. | Self-closing devices |
JP4815024B1 (en) * | 2010-07-02 | 2011-11-16 | 日機装株式会社 | Artificial blood vessels and artificial blood vessel access ports |
JP4991014B2 (en) | 2010-07-07 | 2012-08-01 | 日機装株式会社 | Artificial blood vessel |
US10245413B2 (en) | 2010-10-04 | 2019-04-02 | Covidien Lp | Distal access aspiration guide catheter |
US10130789B2 (en) | 2011-06-30 | 2018-11-20 | Covidien Lp | Distal access aspiration guide catheter |
CN103813817A (en) | 2011-09-06 | 2014-05-21 | 海默斯菲尔有限公司 | Vascular access system with connector |
US20130123621A1 (en) * | 2011-11-10 | 2013-05-16 | John ISHAM | Dual chamber irradiation balloons |
US20130123912A1 (en) * | 2011-11-15 | 2013-05-16 | Boston Scientific Scimed, Inc. | Medical device with nosecone and nosecone tube extension |
EP2983625B1 (en) | 2013-04-13 | 2024-02-14 | Solinas Medical, Inc. | Self-closing devices and apparatus and methods for making and delivering them |
US20150025437A1 (en) * | 2013-07-18 | 2015-01-22 | Cryolife, Inc. | Vascular access system with connector |
ES2689019T3 (en) | 2013-08-13 | 2018-11-08 | Merit Medical Systems, Inc. | Systems and methods for a fluid transport conduit of a vascular access system |
WO2015094514A1 (en) | 2013-12-20 | 2015-06-25 | Cryolife, Inc. | Vascular access system with reinforcement member |
JP5954747B2 (en) * | 2014-03-20 | 2016-07-20 | 朝日インテック株式会社 | catheter |
WO2016004041A1 (en) * | 2014-07-01 | 2016-01-07 | Boston Scientific Scimed, Inc. | Overlapped braid termination |
USD773659S1 (en) * | 2014-08-06 | 2016-12-06 | Huntleigh Technology Limited | Tri pulse connector |
CN105013062B (en) * | 2015-06-29 | 2018-01-26 | 浙江省人民医院 | A kind of radiation can develop terylene set position hemodialysis catheter |
WO2017070696A1 (en) | 2015-10-24 | 2017-04-27 | Kings Systems Corporation | Breathing circuit systems and devices |
US10183159B2 (en) | 2015-12-15 | 2019-01-22 | Heartstitch, Inc. | Constriction valve |
JP7222881B2 (en) | 2016-04-25 | 2023-02-15 | ソリナス メディカル インコーポレイテッド | Self-sealing tubular grafts, patches, methods of making and using same |
WO2018089625A2 (en) | 2016-11-10 | 2018-05-17 | Merit Medical Systems, Inc. | Anchor device for vascular anastomosis |
WO2018132573A1 (en) | 2017-01-12 | 2018-07-19 | Merit Medical Systems, Inc. | Methods and systems for selection and use of connectors between conduits |
EP3573682A4 (en) * | 2017-01-25 | 2020-11-04 | Merit Medical Systems, Inc. | Methods and systems for facilitating laminar flow between conduits |
US11026704B2 (en) | 2017-03-06 | 2021-06-08 | Merit Medical Systems, Inc. | Vascular access assembly declotting systems and methods |
US10925710B2 (en) * | 2017-03-24 | 2021-02-23 | Merit Medical Systems, Inc. | Subcutaneous vascular assemblies for improving blood flow and related devices and methods |
WO2019014444A2 (en) | 2017-07-14 | 2019-01-17 | Merit Medical Systems, Inc. | Releasable conduit connectors |
WO2019018653A1 (en) | 2017-07-20 | 2019-01-24 | Merit Medical Systems, Inc. | Methods and systems for coupling conduits |
US11331458B2 (en) | 2017-10-31 | 2022-05-17 | Merit Medical Systems, Inc. | Subcutaneous vascular assemblies for improving blood flow and related devices and methods |
KR102332076B1 (en) * | 2020-02-10 | 2021-11-26 | 계명대학교 산학협력단 | A brain catheter for optical coherent tomography for intra-cerebral vascular surgery and using method thereof |
KR20230056681A (en) | 2020-08-24 | 2023-04-27 | 주식회사 쿠라레 | Braided cord having variable cross-sectional area and manufacturing method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5405339A (en) * | 1993-09-03 | 1995-04-11 | Medtronic, Inc. | Medical connector and method for connecting medical tubing |
US6308992B1 (en) * | 1998-07-15 | 2001-10-30 | Toyoda Gosei Co., Ltd. | Hose connecting assembly |
US20070167901A1 (en) * | 2005-11-17 | 2007-07-19 | Herrig Judson A | Self-sealing residual compressive stress graft for dialysis |
US8512312B2 (en) * | 2007-05-01 | 2013-08-20 | Medtronic, Inc. | Offset catheter connector, system and method |
Family Cites Families (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3363926A (en) | 1965-05-14 | 1968-01-16 | Nat Lock Co | Locking mechanism for a door lock assembly |
US3490438A (en) | 1967-06-08 | 1970-01-20 | Atomic Energy Commission | Perfusion chamber and cannulae therefor |
US3683926A (en) | 1970-07-09 | 1972-08-15 | Dainippon Pharmaceutical Co | Tube for connecting blood vessels |
US3826257A (en) | 1972-07-14 | 1974-07-30 | T Buselmeier | Prosthetic shunt |
US3818511A (en) | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
US3814137A (en) | 1973-01-26 | 1974-06-04 | Baxter Laboratories Inc | Injection site for flow conduits containing biological fluids |
US3882862A (en) | 1974-01-11 | 1975-05-13 | Olga Berend | Arteriovenous shunt |
US3998222A (en) | 1974-04-15 | 1976-12-21 | Shihata Alfred A | Subcutaneous arterio-venous shunt with valve |
US4076023A (en) | 1975-08-01 | 1978-02-28 | Erika, Inc. | Resealable device for repeated access to conduit lumens |
US4184489A (en) | 1976-10-06 | 1980-01-22 | Cordis Dow Corp. | Infusion tube access site |
US4133312A (en) | 1976-10-13 | 1979-01-09 | Cordis Dow Corp. | Connector for attachment of blood tubing to external arteriovenous shunts and fistulas |
US4214586A (en) | 1978-11-30 | 1980-07-29 | Ethicon, Inc. | Anastomotic coupling device |
US4496350A (en) | 1980-04-08 | 1985-01-29 | Renal Systems, Inc. | Blood access device |
US4318401A (en) | 1980-04-24 | 1982-03-09 | President And Fellows Of Harvard College | Percutaneous vascular access portal and catheter |
DE3019996A1 (en) * | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
US4441215A (en) * | 1980-11-17 | 1984-04-10 | Kaster Robert L | Vascular graft |
US4496349A (en) | 1981-05-08 | 1985-01-29 | Renal Systems, Inc. | Percutaneous implant |
US4503568A (en) * | 1981-11-25 | 1985-03-12 | New England Deaconess Hospital | Small diameter vascular bypass and method |
US4447237A (en) | 1982-05-07 | 1984-05-08 | Dow Corning Corporation | Valving slit construction and cooperating assembly for penetrating the same |
US4550447A (en) | 1983-08-03 | 1985-11-05 | Shiley Incorporated | Vascular graft prosthesis |
GB8407706D0 (en) | 1984-03-24 | 1984-05-02 | Edgealpha Ltd | Lining pipelines in passageways |
US4917087A (en) | 1984-04-10 | 1990-04-17 | Walsh Manufacturing (Mississuaga) Limited | Anastomosis devices, kits and method |
US4772268A (en) * | 1984-05-25 | 1988-09-20 | Cook Incorporated | Two lumen hemodialysis catheter |
US4619641A (en) | 1984-11-13 | 1986-10-28 | Mount Sinai School Of Medicine Of The City University Of New York | Coaxial double lumen anteriovenous grafts |
US4790826A (en) | 1986-03-28 | 1988-12-13 | Elftman Nancy W | Percutaneous access port |
US4753236A (en) | 1986-04-08 | 1988-06-28 | Healey Maureen A | Temporary anastomotic device |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US4734094A (en) | 1986-06-09 | 1988-03-29 | Jacob Erwin T | Catheter and method for cholangiography |
SE455834B (en) | 1986-10-31 | 1988-08-15 | Medinvent Sa | DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS |
US4771777A (en) | 1987-01-06 | 1988-09-20 | Advanced Cardiovascular Systems, Inc. | Perfusion type balloon dilatation catheter, apparatus and method |
US5061276A (en) | 1987-04-28 | 1991-10-29 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
IT1204717B (en) | 1987-06-16 | 1989-03-10 | Claber Spa | VASCULAR ACCESS DEVICE, PARTICULARLY FOR BLOOD PURIFICATION TREATMENTS |
EP0301113B1 (en) | 1987-07-28 | 1992-04-22 | Menck Gmbh | Device for cutting tubular foundation piles under water |
US4877661A (en) | 1987-10-19 | 1989-10-31 | W. L. Gore & Associates, Inc. | Rapidly recoverable PTFE and process therefore |
US5026513A (en) | 1987-10-19 | 1991-06-25 | W. L. Gore & Associates, Inc. | Process for making rapidly recoverable PTFE |
JP2801596B2 (en) | 1987-11-05 | 1998-09-21 | 日本特殊陶業株式会社 | Air-fuel ratio control method |
US4822341A (en) | 1987-11-20 | 1989-04-18 | Impra, Inc. | Vascular access fistula |
US5104402A (en) | 1988-05-25 | 1992-04-14 | Trustees Of The University Of Pennsylvania | Prosthetic vessels for stress at vascular graft anastomoses |
US4929236A (en) | 1988-05-26 | 1990-05-29 | Shiley Infusaid, Inc. | Snap-lock fitting catheter for an implantable device |
US5053023A (en) * | 1988-10-25 | 1991-10-01 | Vas-Cath Incorporated | Catheter for prolonged access |
US5192289A (en) | 1989-03-09 | 1993-03-09 | Avatar Design And Development, Inc. | Anastomosis stent and stent selection system |
US5041098A (en) | 1989-05-19 | 1991-08-20 | Strato Medical Corporation | Vascular access system for extracorporeal treatment of blood |
US4955899A (en) | 1989-05-26 | 1990-09-11 | Impra, Inc. | Longitudinally compliant vascular graft |
US5405320A (en) | 1990-01-08 | 1995-04-11 | The Curators Of The University Of Missouri | Multiple lumen catheter for hemodialysis |
US5350360A (en) | 1990-03-01 | 1994-09-27 | Michigan Transtech Corporation | Implantable access devices |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
JPH0717314Y2 (en) | 1990-10-18 | 1995-04-26 | ソン ホーヨン | Self-expanding intravascular stent |
EP0578777B1 (en) | 1991-04-05 | 1998-01-21 | Boston Scientific Corporation | Convertible catheter assembly |
US5171227A (en) | 1991-04-16 | 1992-12-15 | The Curators Of The University Of Missouri | Separable peritoneal dialysis catheter |
US5399168A (en) | 1991-08-29 | 1995-03-21 | C. R. Bard, Inc. | Implantable plural fluid cavity port |
US5192310A (en) | 1991-09-16 | 1993-03-09 | Atrium Medical Corporation | Self-sealing implantable vascular graft |
US5197976A (en) | 1991-09-16 | 1993-03-30 | Atrium Medical Corporation | Manually separable multi-lumen vascular graft |
US5171305A (en) | 1991-10-17 | 1992-12-15 | Imagyn Medical, Inc. | Linear eversion catheter with reinforced inner body extension |
US5866217A (en) | 1991-11-04 | 1999-02-02 | Possis Medical, Inc. | Silicone composite vascular graft |
IT1253716B (en) | 1991-11-06 | 1995-08-23 | METHOD AND DEVICE FOR CUTTING UNDERWATER STRUCTURES. | |
US5647855A (en) | 1992-05-06 | 1997-07-15 | Trooskin; Stanley Z. | Self-healing diaphragm in a subcutaneous infusion port |
US5607463A (en) | 1993-03-30 | 1997-03-04 | Medtronic, Inc. | Intravascular medical device |
US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5562617A (en) | 1994-01-18 | 1996-10-08 | Finch, Jr.; Charles D. | Implantable vascular device |
US6053901A (en) | 1994-01-18 | 2000-04-25 | Vasca, Inc. | Subcutaneously implanted cannula and method for arterial access |
US5562618A (en) | 1994-01-21 | 1996-10-08 | Sims Deltec, Inc. | Portal assembly and catheter connector |
US5387192A (en) | 1994-01-24 | 1995-02-07 | Sims Deltec, Inc. | Hybrid portal and method |
US5454790A (en) | 1994-05-09 | 1995-10-03 | Innerdyne, Inc. | Method and apparatus for catheterization access |
DE4418910A1 (en) | 1994-05-31 | 1995-12-07 | Mouhamed Kamal Dr Med Koudaimi | Dialysis port system and diaphragm |
US5496294A (en) | 1994-07-08 | 1996-03-05 | Target Therapeutics, Inc. | Catheter with kink-resistant distal tip |
ATE184662T1 (en) * | 1994-07-12 | 1999-10-15 | Eat Elektronische Ateliertechn | METHOD FOR THE TRUE SIMULATION OF A REAL FABRIC CONSISTING OF WARP AND WEFT THREADS |
US5669881A (en) | 1995-01-10 | 1997-09-23 | Baxter International Inc. | Vascular introducer system incorporating inflatable occlusion balloon |
US5591226A (en) | 1995-01-23 | 1997-01-07 | Schneider (Usa) Inc. | Percutaneous stent-graft and method for delivery thereof |
US5904967A (en) | 1995-04-27 | 1999-05-18 | Terumo Kabushiki Kaisha | Puncture resistant medical material |
NZ286445A (en) | 1995-05-16 | 1997-12-19 | Ivac Corp | Needleless luer connector: deformable piston occludes bore |
US5637102A (en) | 1995-05-24 | 1997-06-10 | C. R. Bard, Inc. | Dual-type catheter connection system |
US5674272A (en) | 1995-06-05 | 1997-10-07 | Ventritex, Inc. | Crush resistant implantable lead |
US5743894A (en) | 1995-06-07 | 1998-04-28 | Sherwood Medical Company | Spike port with integrated two way valve access |
EP0840577B1 (en) | 1995-07-07 | 2005-08-24 | W.L. GORE & ASSOCIATES, INC. | Interior liner for tubes, pipes and blood conduits |
US5637088A (en) | 1995-09-14 | 1997-06-10 | Wenner; Donald E. | System for preventing needle displacement in subcutaneous venous access ports |
DE29515546U1 (en) | 1995-09-29 | 1997-01-30 | Schreiber Hans | Vascular port, especially for hemodialysis |
US5800512A (en) | 1996-01-22 | 1998-09-01 | Meadox Medicals, Inc. | PTFE vascular graft |
US6428571B1 (en) | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
US5830184A (en) | 1996-03-06 | 1998-11-03 | Medical Components, Inc. | Composite catheter stabilizing devices, methods of making the same and catheter extracting device |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
JPH09264468A (en) * | 1996-03-28 | 1997-10-07 | Toyoda Gosei Co Ltd | Hose connecting structure |
US5800514A (en) * | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
US5755773A (en) | 1996-06-04 | 1998-05-26 | Medtronic, Inc. | Endoluminal prosthetic bifurcation shunt |
US6007544A (en) | 1996-06-14 | 1999-12-28 | Beth Israel Deaconess Medical Center | Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo |
US5797879A (en) | 1996-08-26 | 1998-08-25 | Decampli; William M. | Apparatus and methods for providing selectively adjustable blood flow through a vascular graft |
US6036702A (en) * | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US6019788A (en) | 1996-11-08 | 2000-02-01 | Gore Enterprise Holdings, Inc. | Vascular shunt graft and junction for same |
US5792104A (en) | 1996-12-10 | 1998-08-11 | Medtronic, Inc. | Dual-reservoir vascular access port |
US5931829A (en) | 1997-01-21 | 1999-08-03 | Vasca, Inc. | Methods and systems for establishing vascular access |
US5957974A (en) | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US6102884A (en) * | 1997-02-07 | 2000-08-15 | Squitieri; Rafael | Squitieri hemodialysis and vascular access systems |
US6231085B1 (en) | 1997-04-21 | 2001-05-15 | Irrigation Development Company | Tubing coupling and hose end combination, and related method |
US6056762A (en) | 1997-05-22 | 2000-05-02 | Kensey Nash Corporation | Anastomosis system and method of use |
US5997562A (en) | 1997-06-13 | 1999-12-07 | Percusurge, Inc. | Medical wire introducer and balloon protective sheath |
US6610004B2 (en) | 1997-10-09 | 2003-08-26 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
FR2770409B1 (en) | 1997-10-31 | 2000-06-23 | Soprane Sa | UNIVERSAL CATHETER |
US5931865A (en) | 1997-11-24 | 1999-08-03 | Gore Enterprise Holdings, Inc. | Multiple-layered leak resistant tube |
US6156016A (en) | 1998-01-06 | 2000-12-05 | Maginot Vascular Systems | Catheter systems and associated methods utilizing removable inner catheter or catheters |
US6261257B1 (en) | 1998-05-26 | 2001-07-17 | Renan P. Uflacker | Dialysis graft system with self-sealing access ports |
US6261255B1 (en) * | 1998-11-06 | 2001-07-17 | Ronald Jay Mullis | Apparatus for vascular access for chronic hemodialysis |
US6338724B1 (en) * | 1999-03-29 | 2002-01-15 | Christos D. Dossa | Arterio-venous interconnection |
US6368347B1 (en) | 1999-04-23 | 2002-04-09 | Sulzer Vascutek Ltd. | Expanded polytetrafluoroethylene vascular graft with coating |
JP4191849B2 (en) | 1999-05-28 | 2008-12-03 | 泉工医科工業株式会社 | Balloon catheter |
US9814869B1 (en) * | 1999-06-15 | 2017-11-14 | C.R. Bard, Inc. | Graft-catheter vascular access system |
US6440161B1 (en) | 1999-07-07 | 2002-08-27 | Endologix, Inc. | Dual wire placement catheter |
US6255396B1 (en) | 1999-09-09 | 2001-07-03 | Baxter International Inc. | Cycloolefin blends and method for solvent bonding polyolefins |
US6319226B1 (en) | 1999-09-20 | 2001-11-20 | Scimed Life Systems, Inc. | Implantable vascular access device |
US6319279B1 (en) | 1999-10-15 | 2001-11-20 | Edwards Lifesciences Corp. | Laminated self-sealing vascular access graft |
US7131959B2 (en) | 2003-01-23 | 2006-11-07 | Integrated Vascular Interventional Technologies, L.C., (“IVIT LC”) | Apparatus and methods for occluding an access tube anastomosed to sidewall of an anatomical vessel |
US6453185B1 (en) | 2000-03-17 | 2002-09-17 | Integra Lifesciences, Inc. | Ventricular catheter with reduced size connector and method of use |
US6436132B1 (en) | 2000-03-30 | 2002-08-20 | Advanced Cardiovascular Systems, Inc. | Composite intraluminal prostheses |
JP4741774B2 (en) | 2000-04-10 | 2011-08-10 | ボストン サイエンティフィック リミテッド | Locking catheter |
US6585762B1 (en) * | 2000-08-10 | 2003-07-01 | Paul Stanish | Arteriovenous grafts and methods of implanting the same |
US6675863B1 (en) | 2000-09-07 | 2004-01-13 | Physical Optics Corporation | Seamless master and method of making same |
US20020049403A1 (en) * | 2000-10-03 | 2002-04-25 | Audencio Alanis | Method and apparatus for permanent vascular access for hemodialysis |
US7244272B2 (en) * | 2000-12-19 | 2007-07-17 | Nicast Ltd. | Vascular prosthesis and method for production thereof |
KR100434720B1 (en) | 2001-01-03 | 2004-06-07 | 이근호 | Method of making a ballon catheter |
US7011645B2 (en) | 2001-01-09 | 2006-03-14 | Rex Medical, L.P. | Dialysis catheter |
US7077829B2 (en) * | 2001-01-09 | 2006-07-18 | Rex Medical, L.P. | Dialysis catheter |
ITGE20010026A1 (en) | 2001-03-20 | 2002-09-20 | Ts Tecnospamec S R L | METHOD FOR CUTTING SUBMERGED STRUCTURES AND APPARATUS SUITABLE FOR CONDUCTING THIS METHOD. |
US7101356B2 (en) * | 2001-03-23 | 2006-09-05 | Miller Stuart H | Implantable vascular access device |
US7828833B2 (en) | 2001-06-11 | 2010-11-09 | Boston Scientific Scimed, Inc. | Composite ePTFE/textile prosthesis |
US7144381B2 (en) | 2001-06-20 | 2006-12-05 | The Regents Of The University Of California | Hemodialysis system and method |
US6692461B2 (en) | 2001-08-07 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Catheter tip |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
US6758836B2 (en) * | 2002-02-07 | 2004-07-06 | C. R. Bard, Inc. | Split tip dialysis catheter |
US7789908B2 (en) | 2002-06-25 | 2010-09-07 | Boston Scientific Scimed, Inc. | Elastomerically impregnated ePTFE to enhance stretch and recovery properties for vascular grafts and coverings |
US6702748B1 (en) | 2002-09-20 | 2004-03-09 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
WO2004032991A2 (en) * | 2002-10-09 | 2004-04-22 | Edrich Vascular Devices, Inc. | Implantable dialysis access port |
US7224272B2 (en) | 2002-12-10 | 2007-05-29 | Current Technologies, Llc | Power line repeater system and method |
US6926735B2 (en) | 2002-12-23 | 2005-08-09 | Scimed Life Systems, Inc. | Multi-lumen vascular grafts having improved self-sealing properties |
US7452374B2 (en) * | 2003-04-24 | 2008-11-18 | Maquet Cardiovascular, Llc | AV grafts with rapid post-operative self-sealing capabilities |
US7025741B2 (en) | 2003-06-06 | 2006-04-11 | Creativasc Medical Llc | Arteriovenous access valve system and process |
WO2004112880A1 (en) * | 2003-06-20 | 2004-12-29 | Ranier Limited | A medical device |
US7211074B2 (en) | 2003-08-12 | 2007-05-01 | Sherwood Services Ag | Valved catheter |
US20050137614A1 (en) * | 2003-10-08 | 2005-06-23 | Porter Christopher H. | System and method for connecting implanted conduits |
US7762977B2 (en) * | 2003-10-08 | 2010-07-27 | Hemosphere, Inc. | Device and method for vascular access |
US20070249986A1 (en) * | 2004-03-15 | 2007-10-25 | Smego Douglas R | Arteriovenous access for hemodialysis employing a vascular balloon catheter and an improved hybrid endovascular technique |
US20050203457A1 (en) * | 2004-03-15 | 2005-09-15 | Smego Douglas R. | Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance |
WO2005094926A1 (en) | 2004-03-23 | 2005-10-13 | Cook Critical Care Incorporated | Percutaneous introducer balloon |
US8282591B2 (en) | 2004-03-29 | 2012-10-09 | Iftikhar Khan | Hybrid arteriovenous shunt |
US20050277899A1 (en) | 2004-06-01 | 2005-12-15 | Conlon Sean P | Method of implanting a fluid injection port |
US7297158B2 (en) * | 2004-06-14 | 2007-11-20 | Thoratec Corporation | Multilayer composite vascular access graft |
WO2006026725A2 (en) | 2004-08-31 | 2006-03-09 | C.R. Bard, Inc. | Self-sealing ptfe graft with kink resistance |
US20070191779A1 (en) * | 2004-08-31 | 2007-08-16 | Igor Shubayev | Percutaneous Vascular Access Device With External Disposable Connector |
US20060058867A1 (en) | 2004-09-15 | 2006-03-16 | Thistle Robert C | Elastomeric radiopaque adhesive composite and prosthesis |
US8029563B2 (en) | 2004-11-29 | 2011-10-04 | Gore Enterprise Holdings, Inc. | Implantable devices with reduced needle puncture site leakage |
US20070078438A1 (en) | 2005-07-05 | 2007-04-05 | Okid Corporation | Catheter assembly and sheath tear assistant tool |
US20070078416A1 (en) | 2005-10-04 | 2007-04-05 | Kenneth Eliasen | Two-piece inline vascular access portal |
US20070088336A1 (en) | 2005-10-17 | 2007-04-19 | Dalton Michael J | Implantable drug delivery depot for subcutaneous delivery of fluids |
US7708722B2 (en) | 2006-01-10 | 2010-05-04 | Stealth Therapeutics, Inc. | Stabilized implantable vascular access port |
US20070265584A1 (en) | 2006-02-15 | 2007-11-15 | Hickman Robert O | Venous prosthesis and vascular graft with access port |
EP1990067A3 (en) * | 2006-02-23 | 2010-12-15 | Levitronix LLC | A pump-outflow-cannula and a blood managing system |
US7438699B2 (en) | 2006-03-06 | 2008-10-21 | Orqis Medical Corporation | Quick priming connectors for blood circuit |
CA2647103A1 (en) * | 2006-03-20 | 2007-09-27 | Medical Components, Inc. | Venous access port assembly and methods of assembly and use |
US7972314B2 (en) * | 2006-03-29 | 2011-07-05 | Medical Components, Inc. | Venous access port base |
US7722665B2 (en) * | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
WO2008097905A1 (en) * | 2007-02-05 | 2008-08-14 | Boston Scientific Scimed, Inc. | Blood access apparatus and method |
-
2009
- 2009-03-03 CA CA2716995A patent/CA2716995C/en active Active
- 2009-03-03 EP EP09718230.7A patent/EP2265300B1/en active Active
- 2009-03-03 ES ES09718230.7T patent/ES2574160T3/en active Active
- 2009-03-03 WO PCT/US2009/035923 patent/WO2009111505A1/en active Application Filing
- 2009-03-03 US US12/397,275 patent/US8079973B2/en active Active
- 2009-03-03 JP JP2010549828A patent/JP5492792B2/en active Active
-
2011
- 2011-06-28 HK HK11106663.0A patent/HK1152502A1/en unknown
- 2011-12-19 US US13/330,360 patent/US20120157971A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5405339A (en) * | 1993-09-03 | 1995-04-11 | Medtronic, Inc. | Medical connector and method for connecting medical tubing |
US6308992B1 (en) * | 1998-07-15 | 2001-10-30 | Toyoda Gosei Co., Ltd. | Hose connecting assembly |
US20070167901A1 (en) * | 2005-11-17 | 2007-07-19 | Herrig Judson A | Self-sealing residual compressive stress graft for dialysis |
US8512312B2 (en) * | 2007-05-01 | 2013-08-20 | Medtronic, Inc. | Offset catheter connector, system and method |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120277729A1 (en) * | 2011-04-29 | 2012-11-01 | Melsheimer Jeffry S | Catheter having a selectively variable degree of flexibility |
US9623206B2 (en) * | 2011-04-29 | 2017-04-18 | Cook Medical Technologies Llc | Catheter having a selectively variable degree of flexibility |
Also Published As
Publication number | Publication date |
---|---|
JP5492792B2 (en) | 2014-05-14 |
CA2716995A1 (en) | 2009-09-11 |
ES2574160T3 (en) | 2016-06-15 |
EP2265300A1 (en) | 2010-12-29 |
HK1152502A1 (en) | 2012-03-02 |
US20090227932A1 (en) | 2009-09-10 |
US8079973B2 (en) | 2011-12-20 |
JP2011514203A (en) | 2011-05-06 |
CA2716995C (en) | 2014-11-04 |
WO2009111505A1 (en) | 2009-09-11 |
EP2265300B1 (en) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8079973B2 (en) | Vascular access system | |
US10792413B2 (en) | Implantable and removable customizable body conduit | |
US20050203457A1 (en) | Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance | |
USRE47154E1 (en) | Device and method for vascular access | |
US11911585B2 (en) | Methods and systems for coupling conduits | |
JP5916632B2 (en) | Apparatus, method and system for establishing supplemental blood flow in the circulatory system | |
US20070249986A1 (en) | Arteriovenous access for hemodialysis employing a vascular balloon catheter and an improved hybrid endovascular technique | |
US20070167901A1 (en) | Self-sealing residual compressive stress graft for dialysis | |
EP3033122B1 (en) | Systems for a fluid carrying conduit of a vascular access system | |
US10682453B2 (en) | Vascular access system with reinforcement member | |
US20230310187A1 (en) | Methods and systems for facilitating laminar flow between conduits | |
US20230149189A1 (en) | Bifurcated vascualr stent and methods of manufacture | |
US20230149149A1 (en) | Bifurcated vascualr stent and methods of manufacture | |
US20220362041A1 (en) | Flow diverting device for dialysis vascular access and methods for use therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA Free format text: SECURITY AGREEMENT;ASSIGNOR:HEMOSPHERE, INC.;REEL/FRAME:028233/0305 Effective date: 20120517 |
|
AS | Assignment |
Owner name: CRYOLIFE, INC., GEORGIA Free format text: MERGER;ASSIGNOR:HEMOSPHERE, INC.;REEL/FRAME:034723/0198 Effective date: 20141231 |
|
AS | Assignment |
Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MARYLAND Free format text: SECURITY INTEREST;ASSIGNOR:CRYOLIFE, INC.;REEL/FRAME:034947/0248 Effective date: 20150209 Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA Free format text: SECURITY INTEREST;ASSIGNOR:CRYOLIFE, INC.;REEL/FRAME:034947/0248 Effective date: 20150209 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT, MARYLAND Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037146/0466 Effective date: 20151118 Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037146/0466 Effective date: 20151118 |
|
AS | Assignment |
Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MARYLAND Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212 Effective date: 20160120 Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MAR Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212 Effective date: 20160120 |
|
AS | Assignment |
Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: HEMOSPHERE, INC., GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.), Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: CRYOLIFE, INC., GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: VALVE SPECIAL PURPOSE CO., LLC, GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: CRYOLIFE ACQUISITION CORPORATION, GEORGIA Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), G Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240 Effective date: 20171201 |